{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:09:30Z","timestamp":1793398170802,"version":"4.5.0"},"reference-count":217,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s00393-022-01294-2","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T10:04:42Z","timestamp":1671098682000},"page":"81-92","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Diagnosis and treatment of adult-onset Still\u2019s disease: a\u00a0concise summary of the German society of rheumatology S2\u00a0guideline","Diagnostik und Behandlung bei M.\u00a0Still des Erwachsenen: kurze Zusammenfassung der S2-Leitlinie der Deutschen Gesellschaft f\u00fcr Rheumatologie"],"prefix":"10.1007","volume":"82","author":[{"given":"Stefan","family":"Vordenb\u00e4umen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugen","family":"Feist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Rech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Fleck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Blank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes-Peter","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"K\u00f6tter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Krusche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamal","family":"Chehab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bimba","family":"Hoyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uta","family":"Kiltz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothea","family":"Fell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Reiners","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Weseloh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,15]]},"reference":[{"key":"1294_CR1","first-page":"414","volume":"132","author":"D Aeberli","year":"2002","unstructured":"Aeberli\u00a0D, Oertle\u00a0S, Mauron\u00a0H et al (2002) Inhibition of the TNF-pathway: use of infliximab and etanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders. Swiss Med Wkly 132:414\u2013422","journal-title":"Swiss Med Wkly"},{"key":"1294_CR2","doi-asserted-by":"publisher","first-page":"996","DOI":"10.3899\/jrheum.161286","volume":"44","author":"SS Ahn","year":"2017","unstructured":"Ahn\u00a0SS, Yoo\u00a0B\u2011W, Jung\u00a0SM et al (2017) Application of the 2016 EULAR\/ACR\/PRINTO classification criteria for macrophage activation syndrome in patients with adult-onset still disease. J\u00a0Rheumatol 44:996\u20131003. https:\/\/doi.org\/10.3899\/jrheum.161286","journal-title":"J Rheumatol"},{"key":"1294_CR3","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s10067-011-1735-0","volume":"30","author":"NE Aikawa","year":"2011","unstructured":"Aikawa\u00a0NE, de Medeiros Ribeiro\u00a0AC, Saad\u00a0CGS et al (2011) Is anti-TNF switching in refractory Still\u2019s disease safe and effective? Clin Rheumatol 30:1129\u20131134. https:\/\/doi.org\/10.1007\/s10067-011-1735-0","journal-title":"Clin Rheumatol"},{"key":"1294_CR4","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1080\/03009740600709816","volume":"35","author":"N Akritidis","year":"2006","unstructured":"Akritidis\u00a0N, Papadopoulos\u00a0A, Pappas\u00a0G (2006) Long-term follow-up of patients with adult-onset Still\u2019s disease. Scand J Rheumatol 35:395\u2013397. https:\/\/doi.org\/10.1080\/03009740600709816","journal-title":"Scand J Rheumatol"},{"key":"1294_CR5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s100670170065","volume":"20","author":"AS Al-Arfaj","year":"2001","unstructured":"Al-Arfaj\u00a0AS, Al-Saleh\u00a0S (2001) Adult-onset still\u2019s disease in Saudi Arabia. Clin Rheumatol 20:197\u2013200","journal-title":"Clin Rheumatol"},{"key":"1294_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-222784","author":"D Aletaha","year":"2022","unstructured":"Aletaha\u00a0D, Kerschbaumer\u00a0A, Kastrati\u00a0K et al (2022) Consensus statement on blocking interleukin\u20116 receptor and interleukin\u20116 in inflammatory conditions: an update. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/ard-2022-222784","journal-title":"Ann Rheum Dis"},{"key":"1294_CR7","first-page":"41","volume":"6","author":"FA Al-Temimi","year":"2006","unstructured":"Al-Temimi\u00a0FA, George\u00a0P (2006) Adult onset still\u2019s disease in Oman. Sultan Qaboos Univ Med\u00a0J 6:41\u201345","journal-title":"Sultan Qaboos Univ Med J"},{"key":"1294_CR8","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.3904\/kjim.2015.322","volume":"32","author":"Y-S An","year":"2017","unstructured":"An\u00a0Y\u2011S, Suh\u00a0C\u2011H, Jung\u00a0J\u2011Y et al (2017) The role of 18F-fluorodeoxyglucose positron emission tomography in the assessment of disease activity of adult-onset Still\u2019s disease. Korean J Intern Med 32:1082\u20131089. https:\/\/doi.org\/10.3904\/kjim.2015.322","journal-title":"Korean J Intern Med"},{"key":"1294_CR9","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1093\/qjmed\/94.10.568","volume":"94","author":"E Andres","year":"2001","unstructured":"Andres\u00a0E (2001) Liver biopsy is not useful in the diagnosis of adult Still\u2019s disease. QJM 94:568\u2013569. https:\/\/doi.org\/10.1093\/qjmed\/94.10.568","journal-title":"QJM"},{"key":"1294_CR10","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S0953-6205(01)00209-6","volume":"13","author":"E Andres","year":"2002","unstructured":"Andres\u00a0E, Ruellan\u00a0A, Pflumio\u00a0F et\u00a0al (2002) Sensitivity of the criteria used to diagnose adult still\u2019s disease in internal medicine practice. a\u00a0study of 17\u00a0cases. Eur J Intern Med 13:136\u2013138","journal-title":"Eur J Intern Med"},{"key":"1294_CR11","unstructured":"Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) (2012) St\u00e4ndige Kommission Leitlinien AWMF-Regelwerk \u201eLeitlinien\u201c"},{"key":"1294_CR12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s13075-017-1406-x","volume":"19","author":"T Asano","year":"2017","unstructured":"Asano\u00a0T, Furukawa\u00a0H, Sato\u00a0S et al (2017) Effects of HLA-DRB1 alleles on susceptibility and clinical manifestations in Japanese patients with adult onset Still\u2019s disease. Arthritis Res Ther 19:199. https:\/\/doi.org\/10.1186\/s13075-017-1406-x","journal-title":"Arthritis Res Ther"},{"key":"1294_CR13","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3109\/14397595.2014.974881","volume":"25","author":"YF Asanuma","year":"2015","unstructured":"Asanuma\u00a0YF, Mimura\u00a0T, Tsuboi\u00a0H et\u00a0al (2015) Nationwide epidemiological survey of 169\u00a0patients with adult Still\u2019s disease in Japan. Mod Rheumatol 25:393\u2013400. https:\/\/doi.org\/10.3109\/14397595.2014.974881","journal-title":"Mod Rheumatol"},{"key":"1294_CR14","first-page":"431","volume":"19","author":"AO Aydintug","year":"1992","unstructured":"Aydintug\u00a0AO, D\u2019Cruz\u00a0D, Cervera\u00a0R et\u00a0al (1992) Low dose methotrexate treatment in adult Still\u2019s disease. J\u00a0Rheumatol 19:431\u2013435","journal-title":"J Rheumatol"},{"key":"1294_CR15","doi-asserted-by":"publisher","first-page":"e451","DOI":"10.1097\/MD.0000000000000451","volume":"94","author":"C-B Bae","year":"2015","unstructured":"Bae\u00a0C\u2011B, Jung\u00a0J\u2011Y, Kim\u00a0H\u2011A, Suh\u00a0C\u2011H (2015) Reactive hemophagocytic syndrome in adult-onset still disease: clinical features, predictive factors, and prognosis in 21 patients. Medicine 94:e451. https:\/\/doi.org\/10.1097\/MD.0000000000000451","journal-title":"Medicine"},{"key":"1294_CR16","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.3899\/jrheum.140651","volume":"41","author":"C-B Bae","year":"2014","unstructured":"Bae\u00a0C\u2011B, Suh\u00a0C\u2011H, An\u00a0J\u2011M et al (2014) Serum S100A12\u00a0May be a\u00a0useful biomarker of disease activity in adult-onset still\u2019s disease. J\u00a0Rheumatol 41:2403\u20132408. https:\/\/doi.org\/10.3899\/jrheum.140651","journal-title":"J Rheumatol"},{"key":"1294_CR17","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3109\/14397595.2014.899178","volume":"26","author":"E Bannai","year":"2016","unstructured":"Bannai\u00a0E, Yamashita\u00a0H, Kaneko\u00a0S et al (2016) Successful tocilizumab therapy in seven patients with refractory adult-onset Still\u2019s disease. Mod Rheumatol 26:297\u2013301","journal-title":"Mod Rheumatol"},{"key":"1294_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10067-011-1761-y","volume":"31","author":"G Baxevanos","year":"2012","unstructured":"Baxevanos\u00a0G, Tzimas\u00a0T, Pappas\u00a0G, Akritidis\u00a0N (2012) A series of 22\u00a0patients with adult-onset Still\u2019s disease presenting with fever of unknown origin. A difficult diagnosis? Clin Rheumatol 31:49\u201353","journal-title":"Clin Rheumatol"},{"key":"1294_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/03009740802179701","volume":"38","author":"H Becker","year":"2009","unstructured":"Becker\u00a0H, Gaubitz\u00a0M, Domschke\u00a0W, Willeke\u00a0P (2009) Potential role of macrophage migration inhibitory factor in adult-onset Still\u2019s disease. Scand J Rheumatol 38:69\u201371","journal-title":"Scand J Rheumatol"},{"key":"1294_CR20","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1007\/s10067-019-04455-y","volume":"38","author":"E Bilgin","year":"2019","unstructured":"Bilgin\u00a0E, Hayran\u00a0M, Erden\u00a0A et al (2019) Proposal for a\u00a0simple algorithm to differentiate adult-onset Still\u2019s disease with other fever of unknown origin causes: a\u00a0longitudinal prospective study. Clin Rheumatol 38:1699\u20131706. https:\/\/doi.org\/10.1007\/s10067-019-04455-y","journal-title":"Clin Rheumatol"},{"key":"1294_CR21","doi-asserted-by":"publisher","first-page":"544412","DOI":"10.3389\/fmed.2020.544412","volume":"7","author":"S Bindoli","year":"2020","unstructured":"Bindoli\u00a0S, Galozzi\u00a0P, Magnani\u00a0F et al (2020) (18)F-Fluorodeoxyglucose positron emission tomography and computed tomography with magnetic resonance for diagnosing adult-onset still\u2019s disease. Front Med 7:544412","journal-title":"Front Med"},{"key":"1294_CR22","doi-asserted-by":"publisher","first-page":"102541","DOI":"10.1016\/j.jaut.2020.102541","volume":"116","author":"Q Bodard","year":"2021","unstructured":"Bodard\u00a0Q, Langlois\u00a0V, Guilpain\u00a0P et al (2021) Cardiac involvement in adult-onset Still\u2019s disease: manifestations, treatments and outcomes in a\u00a0retrospective study of 28\u00a0patients. J\u00a0Autoimmun 116:102541","journal-title":"J Autoimmun"},{"key":"1294_CR23","doi-asserted-by":"publisher","first-page":"4544","DOI":"10.3390\/jcm10194544","volume":"10","author":"C Borciuch","year":"2021","unstructured":"Borciuch\u00a0C, Fauvernier\u00a0M, Gerfaud-Valentin\u00a0M et al (2021) Still\u2019s disease mortality trends in France, 1979\u20132016: a multiple-cause-of-death study. J\u00a0Clin Med 10:4544. https:\/\/doi.org\/10.3390\/jcm10194544","journal-title":"J Clin Med"},{"key":"1294_CR24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1136\/ard.49.5.283","volume":"49","author":"J Cabane","year":"1990","unstructured":"Cabane\u00a0J, Michon\u00a0A, Ziza\u00a0JM et\u00a0al (1990) Comparison of long term evolution of adult onset and juvenile onset Still\u2019s disease, both followed up for more than 10\u00a0years. Ann Rheum Dis 49:283\u2013285. https:\/\/doi.org\/10.1136\/ard.49.5.283","journal-title":"Ann Rheum Dis"},{"key":"1294_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semarthrit.2020.09.014","volume":"51","author":"C Campochiaro","year":"2021","unstructured":"Campochiaro\u00a0C, Farina\u00a0N, Tomelleri\u00a0A et\u00a0al (2021) Drug retention rates of biological agents in adult onset Still\u2019s disease. Semin Arthritis Rheum 51:1\u20136. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.09.014","journal-title":"Semin Arthritis Rheum"},{"key":"1294_CR26","first-page":"329","volume":"19","author":"L Cavagna","year":"2001","unstructured":"Cavagna\u00a0L, Caporali\u00a0R, Epis\u00a0O et\u00a0al (2001) Infliximab in the treatment of adult Still\u2019s disease refractory to conventional therapy. Clin Exp Rheumatol 19:329\u2013332","journal-title":"Clin Exp Rheumatol"},{"key":"1294_CR27","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3109\/03009742.2014.992949","volume":"44","author":"G Cavalli","year":"2015","unstructured":"Cavalli\u00a0G, Franchini\u00a0S, Aiello\u00a0P et al (2015) Efficacy and safety of biological agents in adult-onset Still\u2019s disease. Scand J Rheumatol 44:309\u2013314","journal-title":"Scand J Rheumatol"},{"key":"1294_CR28","volume-title":"Efficacy and safety of biologic agents in adult-onset still\u2019s disease: a long-term follow-up of 19 patients at a\u00a0single referral center","author":"G Cavalli","year":"2013","unstructured":"Cavalli\u00a0G, Franchini\u00a0S, Berti\u00a0A et al (2013) Efficacy and safety of biologic agents in adult-onset still\u2019s disease: a long-term follow-up of 19 patients at a\u00a0single referral center. Abstr. 2028 Am. Coll. Rheumatol. Annu. Meet."},{"key":"1294_CR29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13075-019-1843-9","volume":"21","author":"G Cavalli","year":"2019","unstructured":"Cavalli\u00a0G, Tomelleri\u00a0A, De Luca\u00a0G et al (2019) Efficacy of canakinumab as first-line biologic agent in adult-onset Still\u2019s disease. Arthritis Res Ther 21:54. https:\/\/doi.org\/10.1186\/s13075-019-1843-9","journal-title":"Arthritis Res Ther"},{"key":"1294_CR30","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1136\/ard.2003.013680","volume":"63","author":"DY Chen","year":"2004","unstructured":"Chen\u00a0DY (2004) Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still\u2019s disease. Ann Rheum Dis 63:1300\u20131306. https:\/\/doi.org\/10.1136\/ard.2003.013680","journal-title":"Ann Rheum Dis"},{"key":"1294_CR31","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.3899\/jrheum.090316","volume":"36","author":"D-Y Chen","year":"2009","unstructured":"Chen\u00a0D\u2011Y, Chen\u00a0Y\u2011M, Chen\u00a0H\u2011H et al (2009) Functional association of interleukin 18 gene \u2212607 (C\/A) promoter polymorphisms with disease course in Chinese patients with adult-onset still\u2019s disease. J\u00a0Rheumatol 36:2284\u20132289. https:\/\/doi.org\/10.3899\/jrheum.090316","journal-title":"J Rheumatol"},{"key":"1294_CR32","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3109\/03008200903461462","volume":"51","author":"D-Y Chen","year":"2010","unstructured":"Chen\u00a0D\u2011Y, Chen\u00a0Y\u2011M, Chen\u00a0H\u2011H et al (2010) The associations of circulating CD4 + CD25 high regulatory T cells and TGF\u2011\u03b2 with disease activity and clinical course in patients with adult-onset Still\u2019s disease. Connect Tissue Res 51:370\u2013377. https:\/\/doi.org\/10.3109\/03008200903461462","journal-title":"Connect Tissue Res"},{"key":"1294_CR33","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1136\/ard.2008.098335","volume":"68","author":"D-Y Chen","year":"2009","unstructured":"Chen\u00a0D\u2011Y, Chen\u00a0Y\u2011M, Ho\u00a0W\u2011L et al (2009) Diagnostic value of procalcitonin for differentiation between bacterial infection and non-infectious inflammation in febrile patients with active adult-onset Still\u2019s disease. Ann Rheum Dis 68:1074\u20131075. https:\/\/doi.org\/10.1136\/ard.2008.098335","journal-title":"Ann Rheum Dis"},{"key":"1294_CR34","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1093\/rheumatology\/keq284","volume":"49","author":"D-Y Chen","year":"2010","unstructured":"Chen\u00a0D\u2011Y, Chen\u00a0Y\u2011M, Lan\u00a0J\u2011L et al (2010) Potential role of Th17\u00a0cells in the pathogenesis of adult-onset Still\u2019s disease. Baillieres Clin Rheumatol 49:2305\u20132312. https:\/\/doi.org\/10.1093\/rheumatology\/keq284","journal-title":"Baillieres Clin Rheumatol"},{"key":"1294_CR35","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12891-015-0569-3","volume":"16","author":"D-Y Chen","year":"2015","unstructured":"Chen\u00a0D\u2011Y, Chen\u00a0Y\u2011M, Lin\u00a0C\u2011C et al (2015) The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still\u2019s disease. BMC Musculoskelet Disord 16:111. https:\/\/doi.org\/10.1186\/s12891-015-0569-3","journal-title":"BMC Musculoskelet Disord"},{"key":"1294_CR36","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1741-7015-10-84","volume":"10","author":"D-Y Chen","year":"2012","unstructured":"Chen\u00a0D\u2011Y, Chuang\u00a0H\u2011C, Lan\u00a0J\u2011L et al (2012) Germinal center kinase-like kinase (GLK\/MAP4K3) expression is increased in adult-onset Still\u2019s disease and may act as an activity marker. BMC Med 10:84. https:\/\/doi.org\/10.1186\/1741-7015-10-84","journal-title":"BMC Med"},{"key":"1294_CR37","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1002\/art.23088","volume":"57","author":"D-Y Chen","year":"2007","unstructured":"Chen\u00a0D\u2011Y, Hsieh\u00a0T\u2011Y, Hsieh\u00a0C\u2011W et al (2007) Increased apoptosis of peripheral blood lymphocytes and its association with interleukin-18 in patients with active untreated adult-onset Still\u2019s disease. Arthritis Rheum 57:1530\u20131538. https:\/\/doi.org\/10.1002\/art.23088","journal-title":"Arthritis Rheum"},{"key":"1294_CR38","first-page":"2189","volume":"31","author":"D-Y Chen","year":"2004","unstructured":"Chen\u00a0D\u2011Y, Lan\u00a0J\u2011L, Lin\u00a0F\u2011J, Hsieh\u00a0T\u2011Y (2004) Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still\u2019s disease. J\u00a0Rheumatol 31:2189\u20132198","journal-title":"J Rheumatol"},{"key":"1294_CR39","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/art.21164","volume":"53","author":"D-Y Chen","year":"2005","unstructured":"Chen\u00a0D\u2011Y, Lan\u00a0J\u2011L, Lin\u00a0F\u2011J, Hsieh\u00a0T\u2011Y (2005) Association of intercellular adhesion molecule\u20111 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still\u2019s disease. Arthritis Rheum 53:320\u2013327. https:\/\/doi.org\/10.1002\/art.21164","journal-title":"Arthritis Rheum"},{"key":"1294_CR40","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s10067-006-0378-z","volume":"26","author":"D-Y Chen","year":"2007","unstructured":"Chen\u00a0D\u2011Y, Lan\u00a0J\u2011L, Lin\u00a0F\u2011J, Hsieh\u00a0T\u2011Y (2007) Elevated levels of soluble Fas (APO\u20111, CD95), soluble Fas ligand, and matrix metalloproteinase\u20113 in sera from patients with active untreated adult onset Still\u2019s disease. Clin Rheumatol 26:393\u2013400. https:\/\/doi.org\/10.1007\/s10067-006-0378-z","journal-title":"Clin Rheumatol"},{"key":"1294_CR41","doi-asserted-by":"publisher","first-page":"R39","DOI":"10.1186\/ar4193","volume":"15","author":"D-Y Chen","year":"2013","unstructured":"Chen\u00a0D\u2011Y, Lin\u00a0C\u2011C, Chen\u00a0Y\u2011M et al (2013) Involvement of TLR7 MyD88-dependent signaling pathway in the pathogenesis of adult-onset Still\u2019s disease. Arthritis Res Ther 15:R39. https:\/\/doi.org\/10.1186\/ar4193","journal-title":"Arthritis Res Ther"},{"key":"1294_CR42","doi-asserted-by":"publisher","first-page":"8640719","DOI":"10.1155\/2020\/8640719","volume":"2020","author":"YM Chen","year":"2020","unstructured":"Chen\u00a0YM, Hung\u00a0WT, Chang\u00a0WC et al (2020) Genetic association and expression correlation between colony-stimulating factor 1 gene encoding M\u2011CSF and adult-onset still\u2019s disease. J\u00a0Immunol Res 2020:8640719","journal-title":"J Immunol Res"},{"key":"1294_CR43","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13075-018-1555-6","volume":"20","author":"H Chi","year":"2018","unstructured":"Chi\u00a0H, Liu\u00a0D, Sun\u00a0Y et al (2018) Interleukin-37 is increased in adult-onset Still\u2019s disease and associated with disease activity. Arthritis Res Ther 20:54. https:\/\/doi.org\/10.1186\/s13075-018-1555-6","journal-title":"Arthritis Res Ther"},{"key":"1294_CR44","doi-asserted-by":"publisher","first-page":"621005","DOI":"10.3389\/fmed.2020.621005","volume":"7","author":"H Chi","year":"2020","unstructured":"Chi\u00a0H, Wang\u00a0Z, Meng\u00a0J et al (2020) A cohort study of liver involvement in patients with adult-onset still\u2019s disease: prevalence, characteristics and impact on prognosis. Front Med 7:621005","journal-title":"Front Med"},{"key":"1294_CR45","first-page":"2422","volume":"30","author":"J-H Choi","year":"2003","unstructured":"Choi\u00a0J\u2011H, Suh\u00a0C\u2011H, Lee\u00a0Y\u2011M et al (2003) Serum cytokine profiles in patients with adult onset Still\u2019s disease. J\u00a0Rheumatol 30:2422\u20132427","journal-title":"J Rheumatol"},{"key":"1294_CR46","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10067-013-2381-5","volume":"33","author":"P Cipriani","year":"2014","unstructured":"Cipriani\u00a0P, Ruscitti\u00a0P, Carubbi\u00a0F et al (2014) Tocilizumab for the treatment of adult-onset Still\u2019s disease: results from a\u00a0case series. Clin Rheumatol 33:49\u201355. https:\/\/doi.org\/10.1007\/s10067-013-2381-5","journal-title":"Clin Rheumatol"},{"key":"1294_CR47","volume-title":"Bewertung des Biasrisikos (Risiko systematischer Fehler) in klinischen Studien: ein Manual f\u00fcr die Leitlinienerstellung","author":"Cochrane Deutschland","year":"2016","unstructured":"Cochrane Deutschland, Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften, Institut f\u00fcr Medizinisches Wissensmanagement (2016) Bewertung des Biasrisikos (Risiko systematischer Fehler) in klinischen Studien: ein Manual f\u00fcr die Leitlinienerstellung"},{"key":"1294_CR48","first-page":"156890","volume":"2012","author":"S Colafrancesco","year":"2012","unstructured":"Colafrancesco\u00a0S, Priori\u00a0R, Aless et al (2012) IL-18 serum level in adult onset still\u2019s disease: a marker of disease activity. Int J Inflam 2012:156890","journal-title":"Int J Inflam"},{"key":"1294_CR49","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3389\/fphar.2017.00369","volume":"8","author":"S Colafrancesco","year":"2017","unstructured":"Colafrancesco\u00a0S, Priori\u00a0R, Valesini\u00a0G et al (2017) Response to Interleukin\u20111 inhibitors in 140 Italian patients with adult-onset still\u2019s disease: a multicentre retrospective observational study. Front Pharmacol 8:369","journal-title":"Front Pharmacol"},{"key":"1294_CR50","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1002\/acr.22243","volume":"66","author":"M Colina","year":"2014","unstructured":"Colina\u00a0M, Trotta\u00a0F (2014) Clinical predictors in chronic articular adult-onset still\u2019s disease: comment on the article by Ichida et al: letters. Arthritis Care Res 66:1127\u20131127. https:\/\/doi.org\/10.1002\/acr.22243","journal-title":"Arthritis Care Res"},{"key":"1294_CR51","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.semarthrit.2010.12.006","volume":"41","author":"M Colina","year":"2011","unstructured":"Colina\u00a0M, Zucchini\u00a0W, Ciancio\u00a0G et al (2011) The evolution of adult-onset still disease: an observational and comparative study in a\u00a0cohort of 76 Italian patients. Semin Arthritis Rheum 41:279\u2013285. https:\/\/doi.org\/10.1016\/j.semarthrit.2010.12.006","journal-title":"Semin Arthritis Rheum"},{"key":"1294_CR52","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1007\/s10067-015-3164-y","volume":"35","author":"F Dall\u2019Ara","year":"2016","unstructured":"Dall\u2019Ara\u00a0F, Frassi\u00a0M, Tincani\u00a0A, Air\u00f2\u00a0P (2016) A retrospective study of patients with adult-onset Still\u2019s disease: is pericarditis a\u00a0possible predictor for biological disease-modifying anti-rheumatic drugs need? Clin Rheumatol 35:2117\u20132123","journal-title":"Clin Rheumatol"},{"key":"1294_CR53","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/ajcp\/aqw076","volume":"145","author":"F Debaugnies","year":"2016","unstructured":"Debaugnies\u00a0F, Mahadeb\u00a0B, Ferster\u00a0A et al (2016) Performances of the H\u2011score for diagnosis of hemophagocytic lymphohistiocytosis in adult and pediatric patients. Am J Clin Pathol 145:862\u2013870. https:\/\/doi.org\/10.1093\/ajcp\/aqw076","journal-title":"Am J Clin Pathol"},{"key":"1294_CR54","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.semarthrit.2019.08.005","volume":"50","author":"M Delplanque","year":"2020","unstructured":"Delplanque\u00a0M, Pouchot\u00a0J, Ducharme-B\u00e9nard\u00a0S et al (2020) AA amyloidosis secondary to adult onset Still\u2019s disease: about 19\u00a0cases. Semin Arthritis Rheum 50:156\u2013165","journal-title":"Semin Arthritis Rheum"},{"key":"1294_CR55","doi-asserted-by":"publisher","first-page":"e0235326","DOI":"10.1371\/journal.pone.0235326","volume":"15","author":"P Di Benedetto","year":"2020","unstructured":"Di Benedetto\u00a0P, Cipriani\u00a0P, Iacono\u00a0D et al (2020) Ferritin and C\u2011reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still\u2019s disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort. PLoS ONE 15:e235326","journal-title":"PLoS ONE"},{"key":"1294_CR56","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3899\/jrheum.130881","volume":"41","author":"O Elkayam","year":"2014","unstructured":"Elkayam\u00a0O, Jiries\u00a0N, Dranitzki\u00a0Z et al (2014) Tocilizumab in adult-onset Still\u2019s disease: the Israeli experience. J\u00a0Rheumatol 41:244\u2013247. https:\/\/doi.org\/10.3899\/jrheum.130881","journal-title":"J Rheumatol"},{"key":"1294_CR57","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1080\/03009740510026616","volume":"35","author":"KJ Evensen","year":"2006","unstructured":"Evensen\u00a0KJ, Nossent\u00a0HC (2006) Epidemiology and outcome of adult-onset Still\u2019s disease in Northern Norway. Scand J Rheumatol 35:48\u201351","journal-title":"Scand J Rheumatol"},{"key":"1294_CR58","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/03009740600958504","volume":"36","author":"KJ Evensen","year":"2007","unstructured":"Evensen\u00a0KJ, Swaak\u00a0TJG, Nossent\u00a0JC (2007) Increased ferritin response in adult Still\u2019s disease: specificity and relationship to outcome. Scand J Rheumatol 36:107\u2013110. https:\/\/doi.org\/10.1080\/03009740600958504","journal-title":"Scand J Rheumatol"},{"key":"1294_CR59","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1002\/art.38690","volume":"66","author":"L Fardet","year":"2014","unstructured":"Fardet\u00a0L, Galicier\u00a0L, Lambotte\u00a0O et\u00a0al (2014) Development and validation of the hscore, a\u00a0score for the diagnosis of reactive hemophagocytic syndrome: score for reactive hemophagocytic syndrome. Arthritis Rheumatol 66:2613\u20132620. https:\/\/doi.org\/10.1002\/art.38690","journal-title":"Arthritis Rheumatol"},{"key":"1294_CR60","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/ard.2004.024026","volume":"64","author":"B Fautrel","year":"2005","unstructured":"Fautrel\u00a0B (2005) Tumour necrosis factor blocking agents in refractory adult Still\u2019s disease: an observational study of 20\u00a0cases. Ann Rheum Dis 64:262\u2013266. https:\/\/doi.org\/10.1136\/ard.2004.024026","journal-title":"Ann Rheum Dis"},{"key":"1294_CR61","first-page":"322","volume":"28","author":"B Fautrel","year":"2001","unstructured":"Fautrel\u00a0B, Le Mo\u00ebl\u00a0G, Saint-Marcoux\u00a0B et al (2001) Diagnostic value of ferritin and glycosylated ferritin in adult onset Still\u2019s disease. J\u00a0Rheumatol 28:322\u2013329","journal-title":"J Rheumatol"},{"key":"1294_CR62","first-page":"668","volume":"36","author":"E Feist","year":"2018","unstructured":"Feist\u00a0E, Quartier\u00a0P, Fautrel\u00a0B et al (2018) Efficacy and safety of canakinumab in patients with Still\u2019s disease: exposure-response analysis of pooled systemic juvenile idiopathic arthritis data by age groups. Clin Exp Rheumatol 36:668\u2013675","journal-title":"Clin Exp Rheumatol"},{"key":"1294_CR63","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1002\/art.21061","volume":"52","author":"AA Fitzgerald","year":"2005","unstructured":"Fitzgerald\u00a0AA, LeClercq\u00a0SA, Yan\u00a0A et al (2005) Rapid responses to anakinra in patients with refractory adult-onset Still\u2019s disease. Arthritis Rheum 52:1794\u20131803. https:\/\/doi.org\/10.1002\/art.21061","journal-title":"Arthritis Rheum"},{"key":"1294_CR64","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1111\/j.1600-0560.2010.01570.x","volume":"37","author":"RR Fortna","year":"2010","unstructured":"Fortna\u00a0RR, Gudjonsson\u00a0JE, Seidel\u00a0G et al (2010) Persistent pruritic papules and plaques: a\u00a0characteristic histopathologic presentation seen in a\u00a0subset of patients with adult-onset and juvenile Still\u2019s disease. J\u00a0Cutan Pathol 37:932\u2013937. https:\/\/doi.org\/10.1111\/j.1600-0560.2010.01570.x","journal-title":"J Cutan Pathol"},{"key":"1294_CR65","first-page":"41","volume":"28","author":"S Franchini","year":"2010","unstructured":"Franchini\u00a0S, Dagna\u00a0L, Salvo\u00a0F et\u00a0al (2010) Adult onset Still\u2019s disease: clinical presentation in a\u00a0large cohort of Italian patients. Clin Exp Rheumatol 28:41\u201348","journal-title":"Clin Exp Rheumatol"},{"key":"1294_CR66","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1002\/art.27532","volume":"62","author":"S Franchini","year":"2010","unstructured":"Franchini\u00a0S, Dagna\u00a0L, Salvo\u00a0F et al (2010) Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still\u2019s disease. Arthritis Rheum 62:2530\u20132535. https:\/\/doi.org\/10.1002\/art.27532","journal-title":"Arthritis Rheum"},{"key":"1294_CR67","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1136\/ard.56.2.144","volume":"56","author":"T Fujii","year":"1997","unstructured":"Fujii\u00a0T, Akizuki\u00a0M, Kameda\u00a0H et al (1997) Methotrexate treatment in patients with adult onset Still\u2019s disease--retrospective study of 13 Japanese cases. Ann Rheum Dis 56:144\u2013148. https:\/\/doi.org\/10.1136\/ard.56.2.144","journal-title":"Ann Rheum Dis"},{"key":"1294_CR68","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13075-020-02263-3","volume":"22","author":"Y Fujita","year":"2020","unstructured":"Fujita\u00a0Y, Asano\u00a0T, Matsumoto\u00a0H et\u00a0al (2020) Elevated serum levels of checkpoint molecules in patients with adult Still\u2019s disease. Arthritis Res Ther 22:174. https:\/\/doi.org\/10.1186\/s13075-020-02263-3","journal-title":"Arthritis Res Ther"},{"key":"1294_CR69","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/MD.0000000000000021","volume":"93","author":"M Gerfaud-Valentin","year":"2014","unstructured":"Gerfaud-Valentin\u00a0M, Maucort-Boulch\u00a0D, Hot\u00a0A et al (2014) Adult-onset still disease: manifestations, treatment, outcome, and prognostic factors in 57 patients. Medicine 93:91\u201399. https:\/\/doi.org\/10.1097\/MD.0000000000000021","journal-title":"Medicine"},{"key":"1294_CR70","volume-title":"Long term treatment with Anakinra in patients with adult-onset still disease","author":"C Giampietro","year":"2010","unstructured":"Giampietro\u00a0C, Ridene\u00a0M, Fautrel\u00a0B, Bourgeous\u00a0P (2010) Long term treatment with Anakinra in patients with adult-onset still disease. Abstr. 902 Am. Coll. Rheumatol. Annu. Meet."},{"key":"1294_CR71","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/acr.21901","volume":"65","author":"C Giampietro","year":"2013","unstructured":"Giampietro\u00a0C, Ridene\u00a0M, Lequerre\u00a0T et al (2013) Anakinra in adult-onset still\u2019s disease: long-term treatment in patients resistant to conventional therapy: long-term efficacy and safety of Anakinra in AOSD. Arthritis Care Res 65:822\u2013826. https:\/\/doi.org\/10.1002\/acr.21901","journal-title":"Arthritis Care Res"},{"key":"1294_CR72","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac440","author":"L Gillard","year":"2022","unstructured":"Gillard\u00a0L, Pouchot\u00a0J, Cohen-Aubart\u00a0F et al (2022) JAK inhibitors in difficult-to-treat adult-onset Still\u2019s disease and systemic-onset juvenile idiopathic arthritis. Baillieres Clin Rheumatol. https:\/\/doi.org\/10.1093\/rheumatology\/keac440","journal-title":"Baillieres Clin Rheumatol"},{"key":"1294_CR73","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1093\/rheumatology\/kew300","volume":"55","author":"C Girard","year":"2016","unstructured":"Girard\u00a0C, Rech\u00a0J, Brown\u00a0M et al (2016) Elevated serum levels of free interleukin-18 in adult-onset Still\u2019s disease. Baillieres Clin Rheumatol 55:2237\u20132247. https:\/\/doi.org\/10.1093\/rheumatology\/kew300","journal-title":"Baillieres Clin Rheumatol"},{"key":"1294_CR74","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10067-015-3108-6","volume":"35","author":"Q Guo","year":"2016","unstructured":"Guo\u00a0Q, Zha\u00a0X, Li\u00a0C et al (2016) Serum calprotectin\u2014a promising diagnostic marker for adult-onset Still\u2019s disease. Clin Rheumatol 35:73\u201379. https:\/\/doi.org\/10.1007\/s10067-015-3108-6","journal-title":"Clin Rheumatol"},{"key":"1294_CR75","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s13075-015-0773-4","volume":"17","author":"JH Han","year":"2015","unstructured":"Han\u00a0JH, Suh\u00a0C\u2011H, Jung\u00a0J\u2011Y et al (2015) Association of CXCL10 and CXCL13 levels with disease activity and cutaneous manifestation in active adult-onset Still\u2019s disease. Arthritis Res Ther 17:260. https:\/\/doi.org\/10.1186\/s13075-015-0773-4","journal-title":"Arthritis Res Ther"},{"key":"1294_CR76","doi-asserted-by":"publisher","first-page":"46652","DOI":"10.1038\/srep46652","volume":"7","author":"JH Han","year":"2017","unstructured":"Han\u00a0JH, Suh\u00a0C\u2011H, Jung\u00a0J\u2011Y et al (2017) Elevated circulating levels of the interferon-\u03b3\u2013induced chemokines are associated with disease activity and cutaneous manifestations in adult-onset Still\u2019s disease. Sci Rep 7:46652. https:\/\/doi.org\/10.1038\/srep46652","journal-title":"Sci Rep"},{"key":"1294_CR77","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.10008","author":"SA Hassan","year":"2020","unstructured":"Hassan\u00a0SA, Choudhry\u00a0AS, Jamal\u00a0S et al (2020) Adult onset still\u2019s disease: a retrospective, single-center study. Cureus. https:\/\/doi.org\/10.7759\/cureus.10008","journal-title":"Cureus"},{"key":"1294_CR78","first-page":"2345","volume":"8","author":"D Hong","year":"2014","unstructured":"Hong\u00a0D, Yang\u00a0Z, Han\u00a0S et al (2014) Interleukin 1 inhibition with anakinra in adult-onset Still disease: a\u00a0meta-analysis of its efficacy and safety. Drug Des Devel Ther 8:2345\u20132357","journal-title":"Drug Des Devel Ther"},{"key":"1294_CR79","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.3389\/fimmu.2018.03099","volume":"9","author":"Q Hu","year":"2019","unstructured":"Hu\u00a0Q, Gong\u00a0W, Gu\u00a0J et al (2019) Plasma microRNA profiles as a\u00a0potential biomarker in differentiating adult-onset still\u2019s disease from sepsis. Front Immunol 9:3099. https:\/\/doi.org\/10.3389\/fimmu.2018.03099","journal-title":"Front Immunol"},{"key":"1294_CR80","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1136\/annrheumdis-2019-216699","volume":"79","author":"Q Hu","year":"2020","unstructured":"Hu\u00a0Q, Wang\u00a0M, Jia\u00a0J et al (2020) Tofacitinib in refractory adult-onset Still\u2019s disease: 14\u00a0cases from a\u00a0single centre in China. Ann Rheum Dis 79:842\u2013844. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216699","journal-title":"Ann Rheum Dis"},{"key":"1294_CR81","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1136\/ard.2008.092163","volume":"68","author":"D Huscher","year":"2009","unstructured":"Huscher\u00a0D, Thiele\u00a0K, Gromnica-Ihle\u00a0E et al (2009) Dose-related patterns of glucocorticoid-induced side effects. Ann Rheum Dis 68:1119\u20131124. https:\/\/doi.org\/10.1136\/ard.2008.092163","journal-title":"Ann Rheum Dis"},{"key":"1294_CR82","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1002\/art.10231","volume":"46","author":"ME Husni","year":"2002","unstructured":"Husni\u00a0ME, Maier\u00a0AL, Mease\u00a0PJ et\u00a0al (2002) Etanercept in the treatment of adult patients with Still\u2019s disease. Arthritis Rheum 46:1171\u20131176. https:\/\/doi.org\/10.1002\/art.10231","journal-title":"Arthritis Rheum"},{"key":"1294_CR83","first-page":"47","volume":"31","author":"C Iliou","year":"2013","unstructured":"Iliou\u00a0C, Papagoras\u00a0C, Tsifetaki\u00a0N et al (2013) Adult-onset Still\u2019s disease: clinical, serological and therapeutic considerations. Clin Exp Rheumatol 31:47\u201352","journal-title":"Clin Exp Rheumatol"},{"key":"1294_CR84","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1136\/jcp.2004.018010","volume":"57","author":"YK Jeon","year":"2004","unstructured":"Jeon\u00a0YK (2004) Spectrum of lymph node pathology in adult onset Still\u2019s disease; analysis of 12\u00a0patients with one follow up biopsy. J\u00a0Clin Pathol 57:1052\u20131056. https:\/\/doi.org\/10.1136\/jcp.2004.018010","journal-title":"J Clin Pathol"},{"key":"1294_CR85","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3899\/jrheum.100766","volume":"38","author":"L Jiang","year":"2011","unstructured":"Jiang\u00a0L, Wang\u00a0Z, Dai\u00a0X, Jin\u00a0X (2011) Evaluation of clinical measures and different criteria for diagnosis of adult-onset Still\u2019s disease in a\u00a0Chinese population. J\u00a0Rheumatol 38:741\u2013746. https:\/\/doi.org\/10.3899\/jrheum.100766","journal-title":"J Rheumatol"},{"key":"1294_CR86","doi-asserted-by":"publisher","first-page":"3680","DOI":"10.3892\/mmr.2017.7022","volume":"16","author":"L Jiang","year":"2017","unstructured":"Jiang\u00a0L, Xiu\u00a0Y, Gu\u00a0T et al (2017) Imaging characteristics of adult onset Still\u2019s disease demonstrated with 18F-FDG PET\/CT. Mol Med Rep 16:3680\u20133686. https:\/\/doi.org\/10.3892\/mmr.2017.7022","journal-title":"Mol Med Rep"},{"key":"1294_CR87","first-page":"245","volume":"18","author":"JH Jung","year":"2000","unstructured":"Jung\u00a0JH, Jun\u00a0JB, Yoo\u00a0DH et al (2000) High toxicity of sulfasalazine in adult-onset Still\u2019s disease. Clin Exp Rheumatol 18:245\u2013248","journal-title":"Clin Exp Rheumatol"},{"key":"1294_CR88","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3109\/03009742.2013.824023","volume":"43","author":"KH Jung","year":"2014","unstructured":"Jung\u00a0KH, Kim\u00a0JJ, Lee\u00a0JS et al (2014) Interleukin-18 as an efficient marker for remission and follow-up in patients with inactive adult-onset Still\u2019s disease. Scand J Rheumatol 43:162\u2013169","journal-title":"Scand J Rheumatol"},{"key":"1294_CR89","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.3899\/jrheum.091120","volume":"37","author":"S-Y Jung","year":"2010","unstructured":"Jung\u00a0S\u2011Y, Park\u00a0Y\u2011B, Ha\u00a0Y\u2011J et al (2010) Serum calprotectin as a\u00a0marker for disease activity and severity in adult-onset still\u2019s disease. J\u00a0Rheumatol 37:1029\u20131034. https:\/\/doi.org\/10.3899\/jrheum.091120","journal-title":"J Rheumatol"},{"key":"1294_CR90","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jaut.2016.02.010","volume":"69","author":"U Kalyoncu","year":"2016","unstructured":"Kalyoncu\u00a0U, Solmaz\u00a0D, Emmungil\u00a0H et al (2016) Response rate of initial conventional treatments, disease course, and related factors of patients with adult-onset still\u2019s disease: data from a\u00a0large multicenter cohort. J\u00a0Autoimmun 69:59\u201363. https:\/\/doi.org\/10.1016\/j.jaut.2016.02.010","journal-title":"J Autoimmun"},{"key":"1294_CR91","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1136\/annrheumdis-2018-213920","volume":"77","author":"Y Kaneko","year":"2018","unstructured":"Kaneko\u00a0Y, Kameda\u00a0H, Ikeda\u00a0K et al (2018) Tocilizumab in patients with adult-onset still\u2019s disease refractory to glucocorticoid treatment: a\u00a0randomised, double-blind, placebo-controlled phase III trial. Ann Rheum Dis 77:1720\u20131729. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213920","journal-title":"Ann Rheum Dis"},{"key":"1294_CR92","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1002\/1529-0131(200107)44:7<1716::AID-ART298>3.0.CO;2-I","volume":"44","author":"Y Kawaguchi","year":"2001","unstructured":"Kawaguchi\u00a0Y, Terajima\u00a0H, Harigai\u00a0M et al (2001) Interleukin-18 as a\u00a0novel diagnostic marker and indicator of disease severity in adult-onset Still\u2019s disease. Arthritis Rheum 44:1716\u20131717. https:\/\/doi.org\/10.1002\/1529-0131(200107)44:7\u30081716::AID-ART298\u30093.0.CO;2\u2011I","journal-title":"Arthritis Rheum"},{"key":"1294_CR93","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/1529-0131(200103)44:3<550::AID-ANR103>3.0.CO;2-5","volume":"44","author":"M Kawashima","year":"2001","unstructured":"Kawashima\u00a0M, Yamamura\u00a0M, Taniai\u00a0M et al (2001) Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still\u2019s disease. Arthritis Rheum 44:550\u2013560. https:\/\/doi.org\/10.1002\/1529-0131(200103)44:3\u3008550::AID-ANR103\u30093.0.CO;2\u20115","journal-title":"Arthritis Rheum"},{"key":"1294_CR94","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1136\/annrheumdis-2020-217155","volume":"79","author":"C Kedor","year":"2020","unstructured":"Kedor\u00a0C, Listing\u00a0J, Zernicke\u00a0J et al (2020) Canakinumab for treatment of adult-onset still\u2019s disease to achieve reduction of arthritic manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial. Ann Rheum Dis 79:1090\u20131097","journal-title":"Ann Rheum Dis"},{"key":"1294_CR95","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.3899\/jrheum.120079","volume":"39","author":"H-A Kim","year":"2012","unstructured":"Kim\u00a0H\u2011A, An\u00a0J\u2011M, Nam\u00a0J\u2011Y et al (2012) Serum S100A8\/A9, but not follistatin-like protein 1 and interleukin 18, may be a\u00a0useful biomarker of disease activity in adult-onset Still\u2019s disease. J\u00a0Rheumatol 39:1399\u20131406. https:\/\/doi.org\/10.3899\/jrheum.120079","journal-title":"J Rheumatol"},{"key":"1294_CR96","doi-asserted-by":"publisher","first-page":"e787","DOI":"10.1097\/MD.0000000000000787","volume":"94","author":"H-A Kim","year":"2015","unstructured":"Kim\u00a0H\u2011A, Kwon\u00a0JE, Yim\u00a0H et al (2015) The pathologic findings of skin, lymph node, liver, and bone marrow in patients with adult-onset still disease: a\u00a0comprehensive analysis of 40\u00a0cases. Medicine 94:e787. https:\/\/doi.org\/10.1097\/MD.0000000000000787","journal-title":"Medicine"},{"key":"1294_CR97","first-page":"60","volume":"31","author":"JJ Kim","year":"2013","unstructured":"Kim\u00a0JJ, Kim\u00a0J\u2011K, Shim\u00a0S\u2011C et al (2013) MEFV gene mutations and their clinical significance in Korean patients with adult-onset Still\u2019s disease. Clin Exp Rheumatol 31:60\u201363","journal-title":"Clin Exp Rheumatol"},{"key":"1294_CR98","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s10067-020-05266-2","volume":"40","author":"J-W Kim","year":"2021","unstructured":"Kim\u00a0J\u2011W, Jung\u00a0J\u2011Y, Suh\u00a0C\u2011H, Kim\u00a0H\u2011A (2021) Systemic immune-inflammation index combined with ferritin can serve as a\u00a0reliable assessment score for adult-onset Still\u2019s disease. Clin Rheumatol 40:661\u2013668. https:\/\/doi.org\/10.1007\/s10067-020-05266-2","journal-title":"Clin Rheumatol"},{"key":"1294_CR99","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1007\/s10067-022-06106-1","volume":"41","author":"J-W Kim","year":"2022","unstructured":"Kim\u00a0J\u2011W, Jung\u00a0J\u2011Y, Suh\u00a0C\u2011H, Kim\u00a0H\u2011A (2022) Flare of adult-onset Still\u2019s disease following mRNA COVID-19 vaccination: a\u00a0case report and review of literature. Clin Rheumatol 41:1583\u20131589. https:\/\/doi.org\/10.1007\/s10067-022-06106-1","journal-title":"Clin Rheumatol"},{"key":"1294_CR100","first-page":"28","volume":"32","author":"YJ Kim","year":"2014","unstructured":"Kim\u00a0YJ, Koo\u00a0BS, Kim\u00a0Y\u2011G et al (2014) Clinical features and prognosis in 82\u00a0patients with adult-onset Still\u2019s disease. Clin Exp Rheumatol 32:28\u201333","journal-title":"Clin Exp Rheumatol"},{"key":"1294_CR101","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1080\/14397595.2017.1422231","volume":"28","author":"Y Kirino","year":"2018","unstructured":"Kirino\u00a0Y, Kawaguchi\u00a0Y, Tada\u00a0Y et al (2018) Beneficial use of serum ferritin and heme oxygenase\u20111 as biomarkers in adult-onset still\u2019s disease: a multicenter retrospective study. Mod Rheumatol 28:858\u2013864. https:\/\/doi.org\/10.1080\/14397595.2017.1422231","journal-title":"Mod Rheumatol"},{"key":"1294_CR102","doi-asserted-by":"publisher","first-page":"R616","DOI":"10.1186\/ar1721","volume":"7","author":"Y Kirino","year":"2005","unstructured":"Kirino\u00a0Y, Takeno\u00a0M, Iwasaki\u00a0M et al (2005) Increased serum HO\u20111 in hemophagocytic syndrome and adult-onset Still\u2019s disease: use in the differential diagnosis of hyperferritinemia. Arthritis Res Ther 7:R616\u201324","journal-title":"Arthritis Res Ther"},{"key":"1294_CR103","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13936","author":"S K\u0131r","year":"2021","unstructured":"K\u0131r\u00a0S, \u00d6zgen\u00a0M, Zontul\u00a0S (2021) Adult-onset still\u2019s disease and treatment results with tocilizumab. Int J Clin Pract. https:\/\/doi.org\/10.1111\/ijcp.13936","journal-title":"Int J Clin Pract"},{"key":"1294_CR104","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13075-020-02200-4","volume":"22","author":"T Koga","year":"2020","unstructured":"Koga\u00a0T, Sumiyoshi\u00a0R, Furukawa\u00a0K et al (2020) Interleukin-18 and fibroblast growth factor 2 in combination is a\u00a0useful diagnostic biomarker to distinguish adult-onset Still\u2019s disease from sepsis. Arthritis Res Ther 22:108. https:\/\/doi.org\/10.1186\/s13075-020-02200-4","journal-title":"Arthritis Res Ther"},{"key":"1294_CR105","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1080\/030097400447624","volume":"29","author":"R Koizumi","year":"2000","unstructured":"Koizumi\u00a0R, Tsukada\u00a0Y, Ideura\u00a0H et\u00a0al (2000) Treatment of adult Still\u2019s disease with dexamethasone, an alternative to prednisolone. Scand J Rheumatol 29:396\u2013398","journal-title":"Scand J Rheumatol"},{"key":"1294_CR106","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s10067-003-0775-5","volume":"23","author":"A Kokkinos","year":"2004","unstructured":"Kokkinos\u00a0A, Iliopoulos\u00a0A, Greka\u00a0P et al (2004) Successful treatment of refractory adult-onset Still?s disease with infliximab. A prospective, non-comparative series of four patients. Clin Rheumatol 23:45\u201349. https:\/\/doi.org\/10.1007\/s10067-003-0775-5","journal-title":"Clin Rheumatol"},{"key":"1294_CR107","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s10067-003-0775-5","volume":"23","author":"A Kokkinos","year":"2004","unstructured":"Kokkinos\u00a0A, Iliopoulos\u00a0A, Greka\u00a0P et al (2004) Successful treatment of refractory adult-onset Still\u2019s disease with infliximab. A prospective, non-comparative series of four patients. Clin Rheumatol 23:45\u201349","journal-title":"Clin Rheumatol"},{"key":"1294_CR108","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3109\/03009742.2011.644325","volume":"41","author":"A Komiya","year":"2012","unstructured":"Komiya\u00a0A, Matsui\u00a0T, Nogi\u00a0S et al (2012) Neutrophil CD64 is upregulated in patients with active adult-onset Still\u2019s disease. Scand J Rheumatol 41:156\u2013158. https:\/\/doi.org\/10.3109\/03009742.2011.644325","journal-title":"Scand J Rheumatol"},{"key":"1294_CR109","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s10067-010-1516-1","volume":"29","author":"XD Kong","year":"2010","unstructured":"Kong\u00a0XD, Xu\u00a0D, Zhang\u00a0W et al (2010) Clinical features and prognosis in adult-onset Still\u2019s disease: a\u00a0study of 104\u00a0cases. Clin Rheumatol 29:1015\u20131019","journal-title":"Clin Rheumatol"},{"key":"1294_CR110","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.semarthrit.2007.04.002","volume":"37","author":"I K\u00f6tter","year":"2007","unstructured":"K\u00f6tter\u00a0I, Wacker\u00a0A, Koch\u00a0S et al (2007) Anakinra in patients with treatment-resistant adult-onset Still\u2019s disease: four case reports with serial cytokine measurements and a\u00a0review of the literature. Semin Arthritis Rheum 37:189\u2013197. https:\/\/doi.org\/10.1016\/j.semarthrit.2007.04.002","journal-title":"Semin Arthritis Rheum"},{"key":"1294_CR111","first-page":"iii55","volume":"60","author":"HG Kraetsch","year":"1997","unstructured":"Kraetsch\u00a0HG, Antoni\u00a0C, Kalden\u00a0JR, Manger\u00a0B (1997) Successful treatment of a\u00a0small cohort of patients with adult onset of Still\u2019s disease with infliximab: first experiences. Ann Rheum Dis 60:iii55\u20137","journal-title":"Ann Rheum Dis"},{"key":"1294_CR112","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s41927-019-0053-z","volume":"3","author":"H Kudela","year":"2019","unstructured":"Kudela\u00a0H, Drynda\u00a0S, Lux\u00a0A et al (2019) Comparative study of Interleukin-18 (IL-18) serum levels in adult onset Still\u2019s disease (AOSD) and systemic onset juvenile idiopathic arthritis (sJIA) and its use as a\u00a0biomarker for diagnosis and evaluation of disease activity. BMC Rheumatol 3:4","journal-title":"BMC Rheumatol"},{"key":"1294_CR113","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1007\/s00296-011-2006-8","volume":"32","author":"JS-S Kwok","year":"2012","unstructured":"Kwok\u00a0JS\u2011S, Wong\u00a0PC\u2011H, Luk\u00a0MC, Chan\u00a0MH\u2011M (2012) Use of glycosylated ferritin assay to aid the diagnosis of adult-onset Still\u2019s disease: a\u00a0local laboratory experience in Hong Kong. Rheumatol Int 32:2583\u20132584. https:\/\/doi.org\/10.1007\/s00296-011-2006-8","journal-title":"Rheumatol Int"},{"key":"1294_CR114","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1182\/blood.2018894618","volume":"133","author":"P La Ros\u00e9e","year":"2019","unstructured":"La Ros\u00e9e\u00a0P, Horne\u00a0A, Hines\u00a0M et\u00a0al (2019) Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood 133:2465\u20132477. https:\/\/doi.org\/10.1182\/blood.2018894618","journal-title":"Blood"},{"key":"1294_CR115","first-page":"1027","volume":"30","author":"O Lambotte","year":"2003","unstructured":"Lambotte\u00a0O, Cacoub\u00a0P, Costedoat\u00a0N et\u00a0al (2003) High ferritin and low glycosylated ferritin may also be a\u00a0marker of excessive macrophage activation. J\u00a0Rheumatol 30:1027\u20131028","journal-title":"J Rheumatol"},{"key":"1294_CR116","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1309\/AJCPZE77UAPSMDCD","volume":"144","author":"AR Larson","year":"2015","unstructured":"Larson\u00a0AR, Laga\u00a0AC, Granter\u00a0SR (2015) The spectrum of histopathologic findings in cutaneous lesions in patients with still disease. Am J Clin Pathol 144:945\u2013951. https:\/\/doi.org\/10.1309\/AJCPZE77UAPSMDCD","journal-title":"Am J Clin Pathol"},{"key":"1294_CR117","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.semarthrit.2020.10.011","volume":"51","author":"K Laskari","year":"2021","unstructured":"Laskari\u00a0K, Tektonidou\u00a0MG, Katsiari\u00a0C et\u00a0al (2021) Outcome of refractory to conventional and\/or biologic treatment adult still\u2019s disease following canakinumab treatment: countrywide data in 50\u00a0patients. Semin Arthritis Rheum 51:137\u2013143. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.10.011","journal-title":"Semin Arthritis Rheum"},{"key":"1294_CR118","doi-asserted-by":"publisher","first-page":"R91","DOI":"10.1186\/ar3366","volume":"13","author":"K Laskari","year":"2011","unstructured":"Laskari\u00a0K, Tzioufas\u00a0AG, Moutsopoulos\u00a0HM (2011) Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still\u2019s disease: a\u00a0case-series study. Arthritis Res Ther 13:R91. https:\/\/doi.org\/10.1186\/ar3366","journal-title":"Arthritis Res Ther"},{"key":"1294_CR119","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.semarthrit.2017.07.005","volume":"47","author":"D Lebrun","year":"2018","unstructured":"Lebrun\u00a0D, Mestrallet\u00a0S, Dehoux\u00a0M et al (2018) Validation of the Fautrel classification criteria for adult-onset Still\u2019s disease. Semin Arthritis Rheum 47:578\u2013585. https:\/\/doi.org\/10.1016\/j.semarthrit.2017.07.005","journal-title":"Semin Arthritis Rheum"},{"key":"1294_CR120","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.semarthrit.2012.05.003","volume":"42","author":"JY-Y Lee","year":"2012","unstructured":"Lee\u00a0JY\u2011Y, Hsu\u00a0C\u2011K, Liu\u00a0M\u2011F, Chao\u00a0S\u2011C (2012) Evanescent and persistent pruritic eruptions of adult-onset still disease: a\u00a0clinical and pathologic study of 36\u00a0patients. Semin Arthritis Rheum 42:317\u2013326. https:\/\/doi.org\/10.1016\/j.semarthrit.2012.05.003","journal-title":"Semin Arthritis Rheum"},{"key":"1294_CR121","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3899\/jrheum.080537","volume":"36","author":"S-W Lee","year":"2009","unstructured":"Lee\u00a0S\u2011W, Park\u00a0Y\u2011B, Song\u00a0J\u2011S, Lee\u00a0S\u2011K (2009) The mid-range of the adjusted level of ferritin can predict the chronic course in patients with adult onset Still\u2019s disease. J\u00a0Rheumatol 36:156\u2013162. https:\/\/doi.org\/10.3899\/jrheum.080537","journal-title":"J Rheumatol"},{"key":"1294_CR122","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.semarthrit.2015.11.002","volume":"45","author":"A Lenert","year":"2016","unstructured":"Lenert\u00a0A, Yao\u00a0Q (2016) Macrophage activation syndrome complicating adult onset Still\u2019s disease: a single center case series and comparison with literature. Semin Arthritis Rheum 45:711\u2013716. https:\/\/doi.org\/10.1016\/j.semarthrit.2015.11.002","journal-title":"Semin Arthritis Rheum"},{"key":"1294_CR123","doi-asserted-by":"publisher","first-page":"e678","DOI":"10.1016\/S2665-9913(21)00218-6","volume":"3","author":"F Leone","year":"2021","unstructured":"Leone\u00a0F, Cerasuolo\u00a0PG, Bosello\u00a0SL et al (2021) Adult-onset Still\u2019s disease following COVID-19 vaccination. Lancet Rheumatol 3:e678\u2013e680. https:\/\/doi.org\/10.1016\/S2665-9913(21)00218-6","journal-title":"Lancet Rheumatol"},{"key":"1294_CR124","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1136\/ard.2007.076034","volume":"67","author":"T Lequerr\u00e9","year":"2008","unstructured":"Lequerr\u00e9\u00a0T, Quartier\u00a0P, Rosellini\u00a0D et al (2008) Interleukin\u20111 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France. Ann Rheum Dis 67:302\u2013308","journal-title":"Ann Rheum Dis"},{"key":"1294_CR125","doi-asserted-by":"publisher","first-page":"13477","DOI":"10.1038\/s41598-017-13639-y","volume":"7","author":"T Li","year":"2017","unstructured":"Li\u00a0T, Gu\u00a0L, Wang\u00a0X et al (2017) A pilot study on tocilizumab for treating refractory adult-onset still\u2019s disease. Sci Rep 7:13477. https:\/\/doi.org\/10.1038\/s41598-017-13639-y","journal-title":"Sci Rep"},{"key":"1294_CR126","first-page":"11","volume":"27","author":"E Lim","year":"1998","unstructured":"Lim\u00a0E, Chng\u00a0HH (1998) Adult-onset Still\u2019s disease in an oriental population: manifestations, course and outcome in 16\u00a0patients. Ann Acad Med Singapore 27:11\u201315","journal-title":"Ann Acad Med Singapore"},{"key":"1294_CR127","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s100670050030","volume":"19","author":"SJ Lin","year":"2000","unstructured":"Lin\u00a0SJ, Chao\u00a0HC, Yan\u00a0DC (2000) Different articular outcomes of Still\u2019s disease in Chinese children and adults. Clin Rheumatol 19:127\u2013130. https:\/\/doi.org\/10.1007\/s100670050030","journal-title":"Clin Rheumatol"},{"key":"1294_CR128","first-page":"16634","volume":"8","author":"Z Liu","year":"2015","unstructured":"Liu\u00a0Z, Lv\u00a0X, Tang\u00a0G (2015) Clinical features and prognosis of adult-onset Still\u2019s disease: 75\u00a0cases from China. Int J Clin Exp Med 8:16634\u201316639","journal-title":"Int J Clin Exp Med"},{"key":"1294_CR129","first-page":"427","volume":"20","author":"F Luthi","year":"2002","unstructured":"Luthi\u00a0F, Zufferey\u00a0P, Hofer\u00a0MF, So\u00a0AK (2002) \u201cAdolescent-onset Still\u2019s disease\u201d: characteristics and outcome in comparison with adult-onset Still\u2019s disease. Clin Exp Rheumatol 20:427\u2013430","journal-title":"Clin Exp Rheumatol"},{"key":"1294_CR130","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1080\/14397595.2017.1416924","volume":"28","author":"Y Ma","year":"2018","unstructured":"Ma\u00a0Y, Wu\u00a0M, Zhang\u00a0X et al (2018) Efficacy and safety of tocilizumab with inhibition of interleukin\u20116 in adult-onset still\u2019s disease: a meta-analysis. Mod Rheumatol 28:849\u2013857. https:\/\/doi.org\/10.1080\/14397595.2017.1416924","journal-title":"Mod Rheumatol"},{"key":"1294_CR131","doi-asserted-by":"publisher","first-page":"e19051","DOI":"10.1097\/MD.0000000000019051","volume":"99","author":"N Maeda-Aoyama","year":"2020","unstructured":"Maeda-Aoyama\u00a0N, Hamada-Ode\u00a0K, Taniguchi\u00a0Y et al (2020) Dyskeratotic cells in persistent pruritic skin lesions as a\u00a0prognostic factor in adult-onset Still disease. Medicine 99:e19051","journal-title":"Medicine"},{"key":"1294_CR132","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1136\/ard.54.7.587","volume":"54","author":"G Magadur-Joly","year":"1995","unstructured":"Magadur-Joly\u00a0G, Billaud\u00a0E, Barrier\u00a0JH et al (1995) Epidemiology of adult Still\u2019s disease: estimate of the incidence by a\u00a0retrospective study in west France. Ann Rheum Dis 54:587\u2013590","journal-title":"Ann Rheum Dis"},{"key":"1294_CR133","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2015.22.77.6366","author":"M Mahfoudhi","year":"2015","unstructured":"Mahfoudhi\u00a0M, Shimi\u00a0R, Turki\u00a0S, Kheder\u00a0A (2015) Epidemiology and outcome of articular complications in adult onset still\u2019s disease. Pan Afr Med\u00a0J. https:\/\/doi.org\/10.11604\/pamj.2015.22.77.6366","journal-title":"Pan Afr Med J"},{"key":"1294_CR134","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1080\/14397595.2020.1829340","volume":"31","author":"A Maruyama","year":"2021","unstructured":"Maruyama\u00a0A, Kokuzawa\u00a0A, Yamauchi\u00a0Y et al (2021) Clinical features of elderly-onset adult-onset still\u2019s disease. Mod Rheumatol 31:862\u2013868. https:\/\/doi.org\/10.1080\/14397595.2020.1829340","journal-title":"Mod Rheumatol"},{"key":"1294_CR135","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1093\/rheumatology\/38.5.477","volume":"38","author":"K Matsui","year":"1999","unstructured":"Matsui\u00a0K, Tsuchida\u00a0T, Hiroishi\u00a0K et al (1999) High serum level of macrophage-colony stimulating factor (M-CSF) in adult-onset Still\u2019s disease. Rheumatology 38:477\u2013478. https:\/\/doi.org\/10.1093\/rheumatology\/38.5.477","journal-title":"Rheumatology"},{"key":"1294_CR136","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3109\/s10165-008-0104-6","volume":"18","author":"G Mehrpoor","year":"2008","unstructured":"Mehrpoor\u00a0G, Owlia\u00a0MB, Soleimani\u00a0H, Ayatollahi\u00a0J (2008) Adult-onset Still\u2019s disease: a\u00a0report of 28\u00a0cases and review of the literature. Mod Rheumatol 18:480\u2013485","journal-title":"Mod Rheumatol"},{"key":"1294_CR137","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10067-002-0680-3","volume":"22","author":"A Mert","year":"2003","unstructured":"Mert\u00a0A, Ozaras\u00a0R, Tabak\u00a0F et al (2003) Fever of unknown origin: a\u00a0review of 20\u00a0patients with adult-onset Still\u2019s disease. Clin Rheumatol 22:89\u201393. https:\/\/doi.org\/10.1007\/s10067-002-0680-3","journal-title":"Clin Rheumatol"},{"key":"1294_CR138","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1080\/03009740310000148","volume":"32","author":"JK Min","year":"2003","unstructured":"Min\u00a0JK, Cho\u00a0CS, Kim\u00a0HY, Oh\u00a0EJ (2003) Bone marrow findings in patients with adult Still\u2019s disease. Scand J Rheumatol 32:119\u2013121","journal-title":"Scand J Rheumatol"},{"key":"1294_CR139","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1136\/annrheumdis-2019-215211","volume":"78","author":"F Minoia","year":"2019","unstructured":"Minoia\u00a0F, Bovis\u00a0F, Dav\u00ec\u00a0S et\u00a0al (2019) Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Ann Rheum Dis 78:1357\u20131362. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215211","journal-title":"Ann Rheum Dis"},{"key":"1294_CR140","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3109\/s10165-008-0126-0","volume":"19","author":"M Mitamura","year":"2009","unstructured":"Mitamura\u00a0M, Tada\u00a0Y, Koarada\u00a0S et al (2009) Cyclosporin A treatment for Japanese patients with severe adult-onset Still\u2019s disease. Mod Rheumatol 19:57\u201363","journal-title":"Mod Rheumatol"},{"key":"1294_CR141","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/BF03044924","volume":"92","author":"B Mock","year":"1997","unstructured":"Mock\u00a0B, Hein\u00a0G, Stein\u00a0G (1997) Still-Syndrom des Erwachsenen. Med Klin 92:515\u2013520. https:\/\/doi.org\/10.1007\/BF03044924","journal-title":"Med Klin"},{"key":"1294_CR142","first-page":"2345","volume":"25","author":"CC Mok","year":"1998","unstructured":"Mok\u00a0CC, Lau\u00a0CS, Wong\u00a0RW (1998) Clinical characteristics, treatment, and outcome of adult onset Still\u2019s disease in southern Chinese. J\u00a0Rheumatol 25:2345\u20132351","journal-title":"J Rheumatol"},{"key":"1294_CR143","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/RHU.0b013e31829ce01f","volume":"19","author":"C Moore","year":"2013","unstructured":"Moore\u00a0C, Ormseth\u00a0M, Fuchs\u00a0H (2013) Causes and significance of markedly elevated serum Ferritin levels in an academic medical center. J\u00a0Clin Rheumatol 19:324\u2013328. https:\/\/doi.org\/10.1097\/RHU.0b013e31829ce01f","journal-title":"J Clin Rheumatol"},{"key":"1294_CR144","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/14397595.2017.1351048","volume":"28","author":"R Motohashi","year":"2018","unstructured":"Motohashi\u00a0R, Uchiyama\u00a0K, Ikeuchi\u00a0H et\u00a0al (2018) Five patients who died during treatment for adult Still\u2019s disease. Mod Rheumatol 28:381\u2013382. https:\/\/doi.org\/10.1080\/14397595.2017.1351048","journal-title":"Mod Rheumatol"},{"key":"1294_CR145","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s41927-021-00237-9","volume":"5","author":"F Muench","year":"2021","unstructured":"Muench\u00a0F, Krusche\u00a0M, Sander\u00a0LE et al (2021) Macrophage activation syndrome in a\u00a0patient with adult-onset Still\u2019s disease following first COVID-19 vaccination with BNT162b2. BMC Rheumatol 5:60. https:\/\/doi.org\/10.1186\/s41927-021-00237-9","journal-title":"BMC Rheumatol"},{"key":"1294_CR146","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/1o41c8","author":"V Myachikova","year":"2021","unstructured":"Myachikova\u00a0V, Moiseeva\u00a0O, Konradi\u00a0A et al (2021) A retrospective analysis of colchicine in combination with NSAIDs therapy in patients with systemic form of adult-onset Still\u2019s disease with serositis. Clin Exp Rheumatol. https:\/\/doi.org\/10.55563\/clinexprheumatol\/1o41c8","journal-title":"Clin Exp Rheumatol"},{"issue":"127","key":"1294_CR147","first-page":"11","volume":"38","author":"H Nakamura","year":"2020","unstructured":"Nakamura\u00a0H, Fujieda\u00a0Y, Tarumi\u00a0M et al (2020) Calcineurin inhibitors for adult-onset Still\u2019s disease: a\u00a0multicentre retrospective cohort study. Clin Exp Rheumatol 38(127):11\u201316","journal-title":"Clin Exp Rheumatol"},{"key":"1294_CR148","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3109\/14397595.2014.933997","volume":"26","author":"H Nakamura","year":"2016","unstructured":"Nakamura\u00a0H, Odani\u00a0T, Shimizu\u00a0Y et al (2016) Usefulness of tacrolimus for refractory adult-onset still\u2019s disease: report of six cases. Mod Rheumatol 26:963\u2013967. https:\/\/doi.org\/10.3109\/14397595.2014.933997","journal-title":"Mod Rheumatol"},{"key":"1294_CR149","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.semarthrit.2018.11.007","volume":"49","author":"J Narv\u00e1ez","year":"2019","unstructured":"Narv\u00e1ez\u00a0J, Mora-Limi\u00f1ana\u00a0M, Ros\u00a0I et al (2019) Pulmonary arterial hypertension in adult-onset still\u2019s disease: a case series and systematic review of the literature. Semin Arthritis Rheum 49:162\u2013170. https:\/\/doi.org\/10.1016\/j.semarthrit.2018.11.007","journal-title":"Semin Arthritis Rheum"},{"key":"1294_CR150","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1136\/ard.2009.108068","volume":"69","author":"L Naumann","year":"2010","unstructured":"Naumann\u00a0L, Feist\u00a0E, Natusch\u00a0A et al (2010) IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still\u2019s disease. Ann Rheum Dis 69:466\u2013467. https:\/\/doi.org\/10.1136\/ard.2009.108068","journal-title":"Ann Rheum Dis"},{"key":"1294_CR151","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13054-018-2012-2","volume":"22","author":"A N\u00e9el","year":"2018","unstructured":"N\u00e9el\u00a0A, Wahbi\u00a0A, Tessoulin\u00a0B et al (2018) Diagnostic and management of life-threatening adult-onset Still disease: a\u00a0French nationwide multicenter study and systematic literature review. Crit Care 22:88","journal-title":"Crit Care"},{"key":"1294_CR152","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3109\/14397595.2014.973659","volume":"25","author":"N Nishina","year":"2015","unstructured":"Nishina\u00a0N, Kaneko\u00a0Y, Kameda\u00a0H, Takeuchi\u00a0T (2015) The effect of tocilizumab on preventing relapses in adult-onset still\u2019s disease: a retrospective, single-center study. Mod Rheumatol 25:401\u2013404. https:\/\/doi.org\/10.3109\/14397595.2014.973659","journal-title":"Mod Rheumatol"},{"key":"1294_CR153","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.3899\/jrheum.111549","volume":"39","author":"D Nordstr\u00f6m","year":"2012","unstructured":"Nordstr\u00f6m\u00a0D, Knight\u00a0A, Luukkainen\u00a0R et al (2012) Beneficial effect of interleukin 1 inhibition with anakinra in adult-onset Still\u2019s disease. An open, randomized, multicenter study. J\u00a0Rheumatol 39:2008\u20132011","journal-title":"J Rheumatol"},{"key":"1294_CR154","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s00296-011-1834-x","volume":"32","author":"S Novak","year":"2012","unstructured":"Novak\u00a0S, Anic\u00a0F, Luke-Vrbani\u0107\u00a0TS (2012) Extremely high serum ferritin levels as a\u00a0main diagnostic tool of adult-onset Still\u2019s disease. Rheumatol Int 32:1091\u20131094","journal-title":"Rheumatol Int"},{"key":"1294_CR155","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/RLU.0b013e318212c858","volume":"36","author":"T Okabe","year":"2011","unstructured":"Okabe\u00a0T, Shibata\u00a0H, Shizukuishi\u00a0K et al (2011) F\u201118 FDG uptake patterns and disease activity of collagen vascular diseases-associated arthritis. Clin Nucl Med 36:350\u2013354. https:\/\/doi.org\/10.1097\/RLU.0b013e318212c858","journal-title":"Clin Nucl Med"},{"key":"1294_CR156","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1055\/a-1161-5382","volume":"40","author":"PT Oommen","year":"2020","unstructured":"Oommen\u00a0PT, Hinze\u00a0C, Holzinger\u00a0D et al (2020) Therapie der juvenilen idiopathischen Arthritis (JIA): Aktualisierung der interdisziplin\u00e4ren AWMF-S2k-Leitlinie \u201eTherapie der juvenilen idiopathischen Arthritis\u201c. Arthritis Rheuma 40:260\u2013269. https:\/\/doi.org\/10.1055\/a-1161-5382","journal-title":"Arthritis Rheuma"},{"key":"1294_CR157","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1002\/art.38398","volume":"66","author":"F Ortiz-Sanju\u00e1n","year":"2014","unstructured":"Ortiz-Sanju\u00e1n\u00a0F, Blanco\u00a0R, Calvo-Rio\u00a0V et al (2014) Efficacy of tocilizumab in conventional treatment-refractory adult-onset still\u2019s disease: multicenter retrospective open-label study of thirty-four patients: Tocilizumab in AOSD refractory to standard treatment. Arthritis Rheumatol 66:1659\u20131665. https:\/\/doi.org\/10.1002\/art.38398","journal-title":"Arthritis Rheumatol"},{"key":"1294_CR158","doi-asserted-by":"publisher","first-page":"e1554","DOI":"10.1097\/MD.0000000000001554","volume":"94","author":"F Ortiz-Sanju\u00e1n","year":"2015","unstructured":"Ortiz-Sanju\u00e1n\u00a0F, Blanco\u00a0R, Riancho-Zarrabeitia\u00a0L et al (2015) Efficacy of Anakinra in refractory adult-onset still\u2019s disease: multicenter study of 41 patients and literature review. Medicine 94:e1554. https:\/\/doi.org\/10.1097\/MD.0000000000001554","journal-title":"Medicine"},{"key":"1294_CR159","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s10067-022-06065-7","volume":"41","author":"S Padiyar","year":"2022","unstructured":"Padiyar\u00a0S, Kamath\u00a0N, Mathew\u00a0J et al (2022) New-onset adult-onset Still\u2019s disease-like syndrome after ChAdOx1 nCoV-19 vaccination\u2011a case series with review of literature. Clin Rheumatol 41:1569\u20131575. https:\/\/doi.org\/10.1007\/s10067-022-06065-7","journal-title":"Clin Rheumatol"},{"key":"1294_CR160","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3349\/ymj.2014.55.3.753","volume":"55","author":"H-J Park","year":"2014","unstructured":"Park\u00a0H\u2011J, Ha\u00a0Y\u2011J, Pyo\u00a0J\u2011Y et al (2014) Delta neutrophil index as an early marker for differential diagnosis of adult-onset still\u2019s disease and sepsis. Yonsei Med\u00a0J 55:753. https:\/\/doi.org\/10.3349\/ymj.2014.55.3.753","journal-title":"Yonsei Med J"},{"key":"1294_CR161","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.3904\/kjim.2016.068","volume":"33","author":"H-J Park","year":"2018","unstructured":"Park\u00a0H\u2011J, Song\u00a0J, Park\u00a0Y\u2011B et al (2018) Red blood cell distribution width is useful in discriminating adult onset Still\u2019s disease and sepsis within 24\u00a0hours after hospitalization. Korean J Intern Med 33:1234\u20131240. https:\/\/doi.org\/10.3904\/kjim.2016.068","journal-title":"Korean J Intern Med"},{"key":"1294_CR162","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s10067-005-0138-5","volume":"25","author":"S Pay","year":"2006","unstructured":"Pay\u00a0S, T\u00fcrk\u00e7apar\u00a0N, Kalyoncu\u00a0M et al (2006) A multicenter study of patients with adult-onset Still\u2019s disease compared with systemic juvenile idiopathic arthritis. Clin Rheumatol 25:639\u2013644","journal-title":"Clin Rheumatol"},{"key":"1294_CR163","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1136\/annrheumdis-2012-201409","volume":"71","author":"O Petryna","year":"2012","unstructured":"Petryna\u00a0O, Cush\u00a0JJ, Efthimiou\u00a0P (2012) IL\u20111 Trap rilonacept in refractory adult onset Still\u2019s disease. Ann Rheum Dis 71:2056\u20132058. https:\/\/doi.org\/10.1136\/annrheumdis-2012-201409","journal-title":"Ann Rheum Dis"},{"key":"1294_CR164","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1093\/rheumatology\/keq397","volume":"50","author":"R Priori","year":"2011","unstructured":"Priori\u00a0R, Barone\u00a0F, Alessandri\u00a0C et al (2011) Markedly increased IL-18 liver expression in adult-onset Still\u2019s disease-related hepatitis. Baillieres Clin Rheumatol 50:776\u2013780. https:\/\/doi.org\/10.1093\/rheumatology\/keq397","journal-title":"Baillieres Clin Rheumatol"},{"key":"1294_CR165","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3899\/jrheum.130575","volume":"41","author":"R Priori","year":"2014","unstructured":"Priori\u00a0R, Colafrancesco\u00a0S, Alessandri\u00a0C et al (2014) Interleukin 18: a biomarker for differential diagnosis between adult-onset still\u2019s disease and sepsis. J\u00a0Rheumatol 41:1118\u20131123. https:\/\/doi.org\/10.3899\/jrheum.130575","journal-title":"J Rheumatol"},{"key":"1294_CR166","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/acr.20319","volume":"63","author":"X Pu\u00e9chal","year":"2011","unstructured":"Pu\u00e9chal\u00a0X, DeBandt\u00a0M, Berthelot\u00a0J\u2011M et al (2011) Tocilizumab in refractory adult still\u2019s disease: refractory ASD and tocilizumab. Arthritis Care Res 63:155\u2013159. https:\/\/doi.org\/10.1002\/acr.20319","journal-title":"Arthritis Care Res"},{"key":"1294_CR167","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1111\/his.13785","volume":"74","author":"J Qiao","year":"2019","unstructured":"Qiao\u00a0J, Zhou\u00a0S, Li\u00a0S et al (2019) Histopathological diagnosis of persistent pruritic eruptions associated with adult-onset Still\u2019s disease. Histopathology 74:759\u2013765","journal-title":"Histopathology"},{"key":"1294_CR168","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1136\/ard.2010.129403","volume":"70","author":"J Rech","year":"2011","unstructured":"Rech\u00a0J, Ronneberger\u00a0M, Englbrecht\u00a0M et al (2011) Successful treatment of adult-onset Still\u2019s disease refractory to TNF and IL\u20111 blockade by IL\u20116 receptor blockade. Ann Rheum Dis 70:390\u2013392. https:\/\/doi.org\/10.1136\/ard.2010.129403","journal-title":"Ann Rheum Dis"},{"key":"1294_CR169","doi-asserted-by":"publisher","first-page":"e136","DOI":"10.1111\/1756-185X.12012","volume":"15","author":"VV Reddy Munagala","year":"2012","unstructured":"Reddy Munagala\u00a0VV, Misra\u00a0R, Agarwal\u00a0V et\u00a0al (2012) Adult onset Still\u2019s disease: experience from a\u00a0tertiary care rheumatology unit. Int J Rheum Dis 15:e136\u2013141. https:\/\/doi.org\/10.1111\/1756-185X.12012","journal-title":"Int J Rheum Dis"},{"key":"1294_CR170","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s00296-020-04622-4","volume":"40","author":"M Reihl Crnogaj","year":"2020","unstructured":"Reihl Crnogaj\u00a0M, \u010cubeli\u0107\u00a0D, Babi\u0107\u00a0A et al (2020) Treatment of refractory adult onset Still\u2019s disease with tocilizumab\u2011a single centre experience and literature review. Rheumatol Int 40:1317\u20131325","journal-title":"Rheumatol Int"},{"key":"1294_CR171","first-page":"331","volume":"29","author":"E Riera","year":"2011","unstructured":"Riera\u00a0E, Oliv\u00e9\u00a0A, Narv\u00e1ez\u00a0J et\u00a0al (2011) Adult onset Still\u2019s disease: review of 41\u00a0cases. Clin Exp Rheumatol 29:331\u2013336","journal-title":"Clin Exp Rheumatol"},{"key":"1294_CR172","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1007\/s10067-022-06124-z","volume":"41","author":"R Roongta","year":"2022","unstructured":"Roongta\u00a0R, Mondal\u00a0S, Haldar\u00a0S et\u00a0al (2022) Two flares of Still\u2019s disease after two doses of the ChAdOx1 vaccine. Clin Rheumatol 41:1591\u20131596. https:\/\/doi.org\/10.1007\/s10067-022-06124-z","journal-title":"Clin Rheumatol"},{"key":"1294_CR173","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13023-015-0228-7","volume":"10","author":"L Rossi-Semerano","year":"2015","unstructured":"Rossi-Semerano\u00a0L, Fautrel\u00a0B, Wendling\u00a0D et al (2015) Tolerance and efficacy of off-label anti-interleukin\u20111 treatments in France: a\u00a0nationwide survey. Orphanet J Rare Dis 10:19","journal-title":"Orphanet J Rare Dis"},{"key":"1294_CR174","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13075-020-02245-5","volume":"22","author":"P Ruscitti","year":"2020","unstructured":"Ruscitti\u00a0P, Berardicurti\u00a0O, Iacono\u00a0D et\u00a0al (2020) Parenchymal lung disease in adult onset Still\u2019s disease: an emergent marker of disease severity\u2014characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients. Arthritis Res Ther 22:151. https:\/\/doi.org\/10.1186\/s13075-020-02245-5","journal-title":"Arthritis Res Ther"},{"key":"1294_CR175","doi-asserted-by":"publisher","first-page":"e15123","DOI":"10.1097\/MD.0000000000015123","volume":"98","author":"P Ruscitti","year":"2019","unstructured":"Ruscitti\u00a0P, Cipriani\u00a0P, Liakouli\u00a0V et al (2019) Managing adult-onset still\u2019s disease: the effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study. Medicine 98:e15123. https:\/\/doi.org\/10.1097\/MD.0000000000015123","journal-title":"Medicine"},{"key":"1294_CR176","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00296-019-04358-w","volume":"40","author":"P Ruscitti","year":"2020","unstructured":"Ruscitti\u00a0P, Cipriani\u00a0P, Liakouli\u00a0V et al (2020) Prescribing motivations and patients\u2019 characteristics related to the use of biologic drugs in adult-onset Still\u2019s disease: analysis of a\u00a0multicentre \u201creal-life\u201d cohort. Rheumatol Int 40:107\u2013113. https:\/\/doi.org\/10.1007\/s00296-019-04358-w","journal-title":"Rheumatol Int"},{"key":"1294_CR177","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12916-016-0738-8","volume":"14","author":"P Ruscitti","year":"2016","unstructured":"Ruscitti\u00a0P, Cipriani\u00a0P, Masedu\u00a0F et al (2016) Adult-onset Still\u2019s disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100\u00a0cases from three centers. BMC Med 14:194. https:\/\/doi.org\/10.1186\/s12916-016-0738-8","journal-title":"BMC Med"},{"key":"1294_CR178","doi-asserted-by":"publisher","first-page":"1759720x2093313","DOI":"10.1177\/1759720X20933133","volume":"12","author":"P Ruscitti","year":"2020","unstructured":"Ruscitti\u00a0P, Ursini\u00a0F, Sota\u00a0J et al (2020) The reduction of concomitant glucocorticoids dosage following treatment with IL\u20111 receptor antagonist in adult onset Still\u2019s disease. A systematic review and meta-analysis of observational studies. Ther Adv Musculoskelet Dis 12:1759720x20933133","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"1294_CR179","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.clim.2004.03.023","volume":"112","author":"O Saiki","year":"2004","unstructured":"Saiki\u00a0O, Uda\u00a0H, Nishimoto\u00a0N et\u00a0al (2004) Adult still\u2019s disease reflects a\u00a0th2 rather than a\u00a0th1 cytokine profile. Clin Immunol 112:120\u2013125. https:\/\/doi.org\/10.1016\/j.clim.2004.03.023","journal-title":"Clin Immunol"},{"key":"1294_CR180","first-page":"566","volume":"34","author":"T Sakairi","year":"2016","unstructured":"Sakairi\u00a0T, Hiromura\u00a0K, Kaneko\u00a0Y et al (2016) Histological findings in the spleen affected by adult-onset Still\u2019s disease: a\u00a0report of three cases. Clin Exp Rheumatol 34:566\u2013567","journal-title":"Clin Exp Rheumatol"},{"key":"1294_CR181","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/BF02230329","volume":"15","author":"DM Sanchez Loria","year":"1996","unstructured":"Sanchez Loria\u00a0DM, Moreno Alvarez\u00a0MJ, Barcel\u00f3\u00a0HA et\u00a0al (1996) Sj\u00f6gren\u2019s in adult Still\u2019s disease? Clin Rheumatol 15:133\u2013136","journal-title":"Clin Rheumatol"},{"key":"1294_CR182","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00296-009-1277-9","volume":"30","author":"G Saviola","year":"2010","unstructured":"Saviola\u00a0G, Benucci\u00a0M, Abdi-Ali\u00a0L et al (2010) Clarithromycin in adult-onset Still\u2019s disease: a\u00a0study of 6\u00a0cases. Rheumatol Int 30:555\u2013560. https:\/\/doi.org\/10.1007\/s00296-009-1277-9","journal-title":"Rheumatol Int"},{"key":"1294_CR183","first-page":"47","volume":"72","author":"L Schanberg","year":"2020","unstructured":"Schanberg\u00a0L, Nigrovic\u00a0P, Cooper\u00a0A et al (2020) A randomized, double-blind, placebo-controlled study of anakinra in pediatric and adult patients with still\u2019s disease. Arthritis Rheumatol 72:47\u201349","journal-title":"Arthritis Rheumatol"},{"key":"1294_CR184","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1086\/517085","volume":"26","author":"D Schiller","year":"1998","unstructured":"Schiller\u00a0D, Mittermayer\u00a0H (1998) Hyperferritinemia as a\u00a0marker of Still\u2019s disease. Clin Infect Dis 26:534\u2013535. https:\/\/doi.org\/10.1086\/517085","journal-title":"Clin Infect Dis"},{"key":"1294_CR185","doi-asserted-by":"publisher","DOI":"10.6094\/UNIFR\/12657","volume-title":"Bewertung des Verzerrungsrisikos von systematischen \u00dcbersichtsarbeiten: ein Manual f\u00fcr die Leitlinienerstellung","author":"C Schmucker","year":"2017","unstructured":"Schmucker\u00a0C, Nothacker\u00a0M, M\u00f6hler\u00a0R et\u00a0al (2017) Bewertung des Verzerrungsrisikos von systematischen \u00dcbersichtsarbeiten: ein Manual f\u00fcr die Leitlinienerstellung https:\/\/doi.org\/10.6094\/UNIFR\/12657"},{"key":"1294_CR186","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.4049\/jimmunol.1800667","volume":"201","author":"S Segawa","year":"2018","unstructured":"Segawa\u00a0S, Kondo\u00a0Y, Nakai\u00a0Y et al (2018) Placenta specific 8 suppresses IL-18 production through regulation of autophagy and is associated with adult still disease. J\u00a0Immunol 201:3534\u20133545. https:\/\/doi.org\/10.4049\/jimmunol.1800667","journal-title":"J Immunol"},{"key":"1294_CR187","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1007\/s10067-016-3308-8","volume":"35","author":"P Sfriso","year":"2016","unstructured":"Sfriso\u00a0P, Priori\u00a0R, Valesini\u00a0G et al (2016) Adult-onset Still\u2019s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245\u00a0patients. Clin Rheumatol 35:1683\u20131689. https:\/\/doi.org\/10.1007\/s10067-016-3308-8","journal-title":"Clin Rheumatol"},{"issue":"2","key":"1294_CR188","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/RHU.0000000000000931","volume":"26","author":"T Shimizu","year":"2020","unstructured":"Shimizu\u00a0T, Kikuchi-Taura\u00a0A, Tsuji\u00a0S et al (2020) Up-regulation of CD64 expression on monocytes in patients with active adult-onset still disease: a possible biomarker of disease activity. J\u00a0Clin Rheumatol 26(2):67\u201372. https:\/\/doi.org\/10.1097\/RHU.0000000000000931","journal-title":"J Clin Rheumatol"},{"key":"1294_CR189","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00296-017-3885-0","volume":"38","author":"R Sighart","year":"2018","unstructured":"Sighart\u00a0R, Rech\u00a0J, Hueber\u00a0A et\u00a0al (2018) Evidence for genetic overlap between adult onset Still\u2019s disease and hereditary periodic fever syndromes. Rheumatol Int 38:111\u2013120. https:\/\/doi.org\/10.1007\/s00296-017-3885-0","journal-title":"Rheumatol Int"},{"key":"1294_CR190","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00109-008-0352-0","volume":"86","author":"NN Singh","year":"2008","unstructured":"Singh\u00a0NN, Ramji\u00a0DP (2008) Protein kinase CK2, an important regulator of the inflammatory response? J\u00a0Mol Med (Berl) 86:887\u2013897. https:\/\/doi.org\/10.1007\/s00109-008-0352-0","journal-title":"J Mol Med (Berl)"},{"key":"1294_CR191","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/rheumatology\/31.6.417","volume":"31","author":"YN Singh","year":"1992","unstructured":"Singh\u00a0YN, Adya\u00a0CM, Kumar\u00a0A, Malaviya\u00a0AN (1992) Adult-onset Still\u2019s disease in India. Br J Rheumatol 31:417\u2013419. https:\/\/doi.org\/10.1093\/rheumatology\/31.6.417","journal-title":"Br J Rheumatol"},{"key":"1294_CR192","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/BF01451062","volume":"17","author":"M Sobieska","year":"1998","unstructured":"Sobieska\u00a0M, Fassbender\u00a0K, Aeschlimann\u00a0A et al (1998) Still\u2019s disease in children and adults: a\u00a0distinct pattern of acute-phase proteins. Clin Rheumatol 17:258\u2013260","journal-title":"Clin Rheumatol"},{"key":"1294_CR193","first-page":"S64","volume":"34","author":"ST Song","year":"2016","unstructured":"Song\u00a0ST, Kim\u00a0JJ, Lee\u00a0S et al (2016) Efficacy of tocilizumab therapy in Korean patients with adult-onset Still\u2019s disease: a\u00a0multicentre retrospective study of 22\u00a0cases. Clin Exp Rheumatol 34:S64\u2013S71","journal-title":"Clin Exp Rheumatol"},{"key":"1294_CR194","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3389\/fphar.2019.00918","volume":"10","author":"J Sota","year":"2019","unstructured":"Sota\u00a0J, Rigante\u00a0D, Ruscitti\u00a0P et al (2019) Anakinra drug retention rate and predictive factors of long-term response in systemic juvenile idiopathic arthritis and adult onset still disease. Front Pharmacol 10:918","journal-title":"Front Pharmacol"},{"key":"1294_CR195","doi-asserted-by":"publisher","first-page":"152089","DOI":"10.1016\/j.semarthrit.2022.152089","volume":"57","author":"J Sota","year":"2022","unstructured":"Sota\u00a0J, Vitale\u00a0A, Lopalco\u00a0G et al (2022) Efficacy and safety of tocilizumab in adult-onset Still\u2019s disease: real-life experience from the international AIDA registry. Semin Arthritis Rheum 57:152089. https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152089","journal-title":"Semin Arthritis Rheum"},{"key":"1294_CR196","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3109\/s10165-011-0569-6","volume":"22","author":"R Suematsu","year":"2012","unstructured":"Suematsu\u00a0R, Ohta\u00a0A, Matsuura\u00a0E et\u00a0al (2012) Therapeutic response of patients with adult Still\u2019s disease to biologic agents: multicenter results in Japan. Mod Rheumatol 22:712\u2013719. https:\/\/doi.org\/10.3109\/s10165-011-0569-6","journal-title":"Mod Rheumatol"},{"key":"1294_CR197","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1007\/s10067-019-04642-x","volume":"38","author":"Y Sun","year":"2019","unstructured":"Sun\u00a0Y, Wang\u00a0Z, Chi\u00a0H et al (2019) Elevated serum levels of interleukin-10 in adult-onset Still\u2019s disease are associated with disease activity. Clin Rheumatol 38:3205\u20133210. https:\/\/doi.org\/10.1007\/s10067-019-04642-x","journal-title":"Clin Rheumatol"},{"issue":"121","key":"1294_CR198","first-page":"23","volume":"37","author":"Y Takakuwa","year":"2019","unstructured":"Takakuwa\u00a0Y, Hanaoka\u00a0H, Kiyokawa\u00a0T et al (2019) Adult-onset Still\u2019s disease-associated interstitial lung disease represents severe phenotype of the disease with higher rate of haemophagocytic syndrome and relapse. Clin Exp Rheumatol 37(121):23\u201327","journal-title":"Clin Exp Rheumatol"},{"key":"1294_CR199","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1002\/art.40522","volume":"70","author":"S Ugurlu","year":"2018","unstructured":"Ugurlu\u00a0S, Guzelant\u00a0G, Yurttas\u00a0B et al (2018) Canakinumab treatment in adult-onset still\u2019s disease: case series. Arthritis Rheumatol 70:1450","journal-title":"Arthritis Rheumatol"},{"key":"1294_CR200","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s10067-006-0440-x","volume":"26","author":"SS Uppal","year":"2007","unstructured":"Uppal\u00a0SS, Al-Mutairi\u00a0M, Hayat\u00a0S et al (2007) Ten years of clinical experience with adult onset Still\u2019s disease: is the outcome improving? Clin Rheumatol 26:1055\u20131060. https:\/\/doi.org\/10.1007\/s10067-006-0440-x","journal-title":"Clin Rheumatol"},{"key":"1294_CR201","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1093\/rheumatology\/34.5.429","volume":"34","author":"SS Uppal","year":"1995","unstructured":"Uppal\u00a0SS, Pande\u00a0IR, Kumar\u00a0A et\u00a0al (1995) Adult onset Still\u2019s disease in northern India: comparison with juvenile onset Still\u2019s disease. Br J Rheumatol 34:429\u2013434. https:\/\/doi.org\/10.1093\/rheumatology\/34.5.429","journal-title":"Br J Rheumatol"},{"key":"1294_CR202","first-page":"514","volume":"30","author":"S Vanderschueren","year":"2012","unstructured":"Vanderschueren\u00a0S, Hermans\u00a0F, De Munter\u00a0P, Knockaert\u00a0D (2012) Adult-onset Still\u2019s disease: still a\u00a0diagnosis of exclusion. A nested case-control study in patients with fever of unknown origin. Clin Exp Rheumatol 30:514\u2013519","journal-title":"Clin Exp Rheumatol"},{"key":"1294_CR203","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13075-019-1838-6","volume":"21","author":"F Vercruysse","year":"2019","unstructured":"Vercruysse\u00a0F, Barnetche\u00a0T, Lazaro\u00a0E et al (2019) Adult-onset Still\u2019s disease biological treatment strategy may depend on the phenotypic dichotomy. Arthritis Res Ther 21:53. https:\/\/doi.org\/10.1186\/s13075-019-1838-6","journal-title":"Arthritis Res Ther"},{"key":"1294_CR204","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1136\/ard.59.5.347","volume":"59","author":"S Vignes","year":"2000","unstructured":"Vignes\u00a0S, Le Mo\u00ebl\u00a0G, Fautrel\u00a0B et\u00a0al (2000) Percentage of glycosylated serum ferritin remains low throughout the course of adult onset Still\u2019s disease. Ann Rheum Dis 59:347\u2013350. https:\/\/doi.org\/10.1136\/ard.59.5.347","journal-title":"Ann Rheum Dis"},{"key":"1294_CR205","doi-asserted-by":"publisher","first-page":"8054961","DOI":"10.1155\/2020\/8054961","volume":"2020","author":"A Vitale","year":"2020","unstructured":"Vitale\u00a0A, Berlengiero\u00a0V, Sota\u00a0J et al (2020) Real-life data on the efficacy of canakinumab in patients with adult-onset still\u2019s disease. Mediators Inflamm 2020:8054961","journal-title":"Mediators Inflamm."},{"key":"1294_CR206","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3389\/fphar.2019.00296","volume":"10","author":"A Vitale","year":"2019","unstructured":"Vitale\u00a0A, Cavalli\u00a0G, Colafrancesco\u00a0S et al (2019) Long-term retention rate of Anakinra in adult onset still\u2019s disease and predictive factors for treatment response. Front Pharmacol 10:296","journal-title":"Front Pharmacol"},{"key":"1294_CR207","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fmed.2020.00042","volume":"7","author":"A Vitale","year":"2020","unstructured":"Vitale\u00a0A, Cavalli\u00a0G, Ruscitti\u00a0P et\u00a0al (2020) Comparison of early vs. delayed Anakinra treatment in patients with adult onset still\u2019s disease and effect on clinical and laboratory outcomes. Front Med 7:42","journal-title":"Front Med"},{"key":"1294_CR208","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00380","author":"A Vitale","year":"2016","unstructured":"Vitale\u00a0A, Insalaco\u00a0A, Sfriso\u00a0P et al (2016) A snapshot on the on-label and off-label use of the Interleukin\u20111 inhibitors in Italy among rheumatologists and pediatric rheumatologists: a nationwide multi-center retrospective observational study. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2016.00380","journal-title":"Front Pharmacol"},{"key":"1294_CR209","doi-asserted-by":"publisher","first-page":"j1415","DOI":"10.1136\/bmj.j1415","volume":"357","author":"AK Waljee","year":"2017","unstructured":"Waljee\u00a0AK, Rogers\u00a0MAM, Lin\u00a0P et\u00a0al (2017) Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study. BMJ 357:j1415. https:\/\/doi.org\/10.1136\/bmj.j1415","journal-title":"BMJ"},{"key":"1294_CR210","doi-asserted-by":"publisher","first-page":"e16682","DOI":"10.1097\/MD.0000000000016682","volume":"98","author":"C Wang","year":"2019","unstructured":"Wang\u00a0C, Guo\u00a0S, Wang\u00a0L, Shen\u00a0H (2019) Refractory adult-onset Still disease treated by tocilizumab combined with methotrexate: a STROBE-compliant article. Medicine 98:e16682. https:\/\/doi.org\/10.1097\/MD.0000000000016682","journal-title":"Medicine"},{"key":"1294_CR211","doi-asserted-by":"publisher","first-page":"R65","DOI":"10.1186\/ar4239","volume":"15","author":"F-F Wang","year":"2013","unstructured":"Wang\u00a0F\u2011F, Huang\u00a0X\u2011F, Shen\u00a0N et al (2013) A genetic role for macrophage migration inhibitory factor (MIF) in adult-onset Still\u2019s disease. Arthritis Res Ther 15:R65. https:\/\/doi.org\/10.1186\/ar4239","journal-title":"Arthritis Res Ther"},{"key":"1294_CR212","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.220219","author":"J Weng","year":"2022","unstructured":"Weng\u00a0J, Zhou\u00a0LL, Hahn\u00a0T et al (2022) Adult-onset Still disease after Chadox1 nCOV-19 vaccination. J\u00a0Rheumatol. https:\/\/doi.org\/10.3899\/jrheum.220219","journal-title":"J Rheumatol"},{"key":"1294_CR213","doi-asserted-by":"publisher","first-page":"325","DOI":"10.7326\/M20-0432","volume":"173","author":"T-C Yao","year":"2020","unstructured":"Yao\u00a0T\u2011C, Huang\u00a0Y\u2011W, Chang\u00a0S\u2011M et al (2020) Association between oral corticosteroid bursts and severe adverse events : a nationwide population-based cohort study. Ann Intern Med 173:325\u2013330. https:\/\/doi.org\/10.7326\/M20-0432","journal-title":"Ann Intern Med"},{"key":"1294_CR214","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.jaad.2005.02.032","volume":"52","author":"JY Lee","year":"2005","unstructured":"Lee\u00a0JY, Yang\u00a0C\u2011C, Hsu\u00a0MM (2005) Histopathology of persistent papules and plaques in adult-onset Still\u2019s disease. J\u00a0Am Acad Dermatol 52:1003\u20131008. https:\/\/doi.org\/10.1016\/j.jaad.2005.02.032","journal-title":"J Am Acad Dermatol"},{"key":"1294_CR215","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.3899\/jrheum.080365","volume":"36","author":"T Zeng","year":"2009","unstructured":"Zeng\u00a0T, Zou\u00a0Y\u2011Q, Wu\u00a0M\u2011F, Yang\u00a0C\u2011D (2009) Clinical features and prognosis of adult-onset still\u2019s disease: 61 cases from China. J\u00a0Rheumatol 36:1026\u20131031. https:\/\/doi.org\/10.3899\/jrheum.080365","journal-title":"J Rheumatol"},{"key":"1294_CR216","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217917","author":"L Zhang","year":"2020","unstructured":"Zhang\u00a0L, Yang\u00a0X, Li\u00a0T\u2011F et al (2020) Comparison of MS score and HScore for the diagnosis of adult-onset Still\u2019s disease-associated macrophage activation syndrome. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217917","journal-title":"Ann Rheum Dis"},{"key":"1294_CR217","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.21037\/apm-20-268","volume":"9","author":"M Zhang","year":"2020","unstructured":"Zhang\u00a0M, Wang\u00a0Y, Li\u00a0J, Zhou\u00a0J (2020) Adult-onset Still\u2019s disease presenting as fever of unknown origin: a\u00a0single-center retrospective observational study from China. Ann Palliat Med 9:2786\u20132792. https:\/\/doi.org\/10.21037\/apm-20-268","journal-title":"Ann Palliat Med"}],"updated-by":[{"DOI":"10.1007\/s00393-023-01337-2","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:00:00Z","timestamp":1675900800000}}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-022-01294-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-022-01294-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-022-01294-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T20:17:01Z","timestamp":1677010621000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-022-01294-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,15]]},"references-count":217,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["1294"],"URL":"https:\/\/doi.org\/10.1007\/s00393-022-01294-2","relation":{"erratum":[{"id-type":"doi","id":"10.1007\/s00393-023-01337-2","asserted-by":"object"}]},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,15]]},"assertion":[{"value":"3 November 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2023","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Erratum","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An Erratum to this paper has been published:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00393-023-01337-2","URL":"https:\/\/doi.org\/10.1007\/s00393-023-01337-2","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}